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Abstract 
CLPP (caseinolytic mitochondrial matrix peptidase proteolytic subunit) is a highly 
conserved serine protease. Molecular and structural studies in E. coli and other 
prokaryotes have revealed CLPP specific substrates and the mechanisms underlying their 
identification and subsequent degradation. These studies showed that ClpXP is involved 
in DNA damage repair, stationary-phase gene expression, and ssrA-mediated protein 
quality control. Similarly, diverse roles for the eukaryotic CLPP have been suggested. In 
the filamentous fungus Podospora anserine Clpp depletion promotes longevity. In 
Caenorhabditis elegans it has been demonstrated that CLPP have a central role in 
mediating the UPRmt signals. Loss of function CLPP mutations in humans cause Perrault 
syndrome that results in ovarian failure and sensorineural hearing loss accompanied with 
shorter stature. Despite this we still have a very limited knowledge about the functional 
role of eukaryotic CLPP, its specific substrates and underlying molecular mechanism.  
In order to decipher the in vivo role of CLPP in mammals we have developed a CLPP 
deficient mouse model (Clpp-/-). Interestingly, only about half of Clpp knockout mice 
according to Mendelian proportion (12,5%) are born from intercrossing of Clpp+/- mice. 
These mice are infertile and born ~ 30% smaller than littermates. CLPP deficient mice 
faithfully replicate the phenotypes observed in human patients. On the molecular level 
CLPP deficiency leads to an early specific decrease in Complex I activity, followed by a 
decrease in Complex IV activity later in life. Furthermore, we observed a decrease in 
mitochondrial translation, which is compensated for by upregulation of mitochondrial 
transcription. This suggests a direct or indirect role of CLPP in the process of 
mitochondrial protein synthesis. Gradient sedimentation analysis demonstrates an 
increase in the steady state levels of small ribosomal subunits, while large ribosomal 
subunits and monosomes are present in almost normal levels. We also observed an 
impairment of 12S rRNA assembly into monosomes leading to lower loading of mt-
mRNAs. This indicates complications in the function of monosomes. Search for CLPXP 
substrates and interactors revealed two candidates that are likely to be involved in this 
process. We show that ERAL1 is one of the substrates of CLPP that is likely causing 
defective 12S rRNA assembly into the small ribosomal subunit. Additionally, p32, a 
CLPP interactor is permanently bound to the mitoribosomes. We believe that through 
 xiv 
interaction with CLPXP, these proteins are involved in resolution of stalled ribosomes. 
We are currently working further on elucidating the molecular mechanism underlying 
impaired mitochondrial translation. 
 
 xv 
Zusammenfassung 
Die Casein abbauende Peptidase P (caseinolytic mitochondrial matrix peptidase 
proteolytic subunit, CLPP) ist eine hoch konservierte Serinprotease. Molekulare und 
strukturelle Untersuchungen in E. coli und anderen Prokaryoten haben CLPP-spezifische 
Substrate identifiziert und die zugrunde liegenden Mechanismen der nachfolgenden 
Degradierung dieser Substrate aufgezeigt. Diesen Studien zufolge ist ClpXP bei der 
Reparatur von DNA-Schäden, in der Genexpression der stationären Phase sowie in der 
ssrA-vermittelten Proteinqualitätskontrolle involviert. In ähnlicher Weise wurden 
verschiedene Rollen für die eukaryotische CLPP postuliert. Im filamentösen Pilz 
Podospora anserine förderte die Depletion von CLPP die Langlebigkeit. In 
Caenorhabditis elegans wurde gezeigt, dass CLPP eine zentrale Rolle in der Vermittlung 
der Signale in der mitochondrialen ungefalteten Proteinantwort (mitochondrial unfolded 
protein response, UPRmt) spielt. Mutationen, die den Verlust der Funktion von CLPP zur 
Folge haben, verursachen beim Menschen das Perrault Syndrom, das durch 
Gonadendysgenesie und Innenohrschwerhörigkeit, assoziiert mit Minderwuchs, 
charakterisiert ist. Trotz dieser Bemühungen ist unser Wissen über die funktionelle Rolle 
der eukaryotischen CLPP, deren Substrate und über die zugrunde liegenden 
Mechanismen ihrer Regulation nur sehr begrenzt. 
Um die in vivo Rolle von CLPP in Säugern zu entschlüsseln, haben wir ein CLPP-
defizientes Mausmodell (Clpp-/-) entwickelt. Interessant ist, dass nur etwa die Hälfte 
Clpp Knockout-Mäuse nach den Mendelschen Regeln (12,5%) nach der Kreuzung von 
heterozygoten Clpp +/- Mäuse geboren wird. Diese Mäuse sind unfruchtbar und etwa 
30% kleiner ist als die nicht betroffenen Wurfgeschwistern. CLPP-defiziente Mäuse 
replizieren getreu die bei den menschlichen Patienten beobachteten Phänotypen. Auf 
molekularer Ebene führt der Verlust von CLPP zu einer spezifischen Abnahme der 
Komplex I-Aktivität im frühen Alter, gefolgt von einer Abnahme der Komplex IV-
Aktivität in späteren Lebensabschnitten. Ferner beobachteten wir eine Abnahme in der 
mitochondrialen Translation, die durch eine Hochregulation der mitochondrialen 
Transkription kompensiert wird. Dies lässt auf eine direkte oder indirekte Rolle von 
CLPP im mitochondrialen Proteinsyntheseprozess vermuten. Die 
Gradientensedimentationanalyse zeigt einen Anstieg der kleinen ribosomalen 
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Untereinheiten, während die großen ribosomalen Untereinheiten und die Monosomen in 
fast normalen Werten vorhanden sind. Wir beobachteten auch eine Beeinträchtigung der 
Assemblierung der 12S rRNA in das Monosom, was zu einer verringerten Beladung der 
mitochondrialen mRNAs führt. Dies weist auf Komplikationen in der Funktion der 
Monosomen hin. Die Suche nach den ClpXP-Substraten und möglichen 
Interaktionspartnern ergab zwei Kandidaten, die wahrscheinlich in diesem Prozess 
involviert sind. Wir konnten zeigen, dass ERAL1 eines der Substrate von CLPP ist, das 
wahrscheinlich die defekte Assemblierung der 12S rRNA in die kleine ribosomale 
Untereinheit verursacht. Ferner scheint p32 ein CLPP-Interaktionspartner zu sein, der fest 
an den mitochondrialen Ribosomen gebunden ist. Wir glauben, dass diese Proteine durch 
die Interaktion mit ClpXP bei der Auflösung der ins Stocken geratenen Ribosomen 
beteiligt sind. Zurzeit arbeiten wir weiter an der Aufklärung der molekularen 
Mechanismen, die die mitochondriale Translation beeinträchtigen. 
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1. Introduction 
 
1.1. Mitochondria 
Mitochondria are small, highly specialized membrane enclosed organelles present in 
most eukaryotic cells. The word mitochondrion is derived from Greek words mitos  
(thread) and chondros  (granule) and known as the “energy powerhouse of the cell” 1,2. 
Mitochondria possess its own genome and this is explained by the widely accepted 
endosymbiotic theory 3. The endosymbiotic hypothesis (‘endo-’ for internal, and 
‘symbiont’ as in a partner in a mutually beneficial relationship) postulates that 
mitochondrion evolved from within the bacterial phylum a-proteobacteria via symbiosis 
within a eukaryotic host cell that happened over two billion years ago. Further 
phylogenetic reconstruction pointed specifically towards the Rickettsiaceaea family to be 
most closely related to mitochondria 4. These phylogenetic studies have revealed that a 
number of ancestral bacterial genes have been transferred to nuclear genome 
(endosymbiotic gene transfer) resulting in reduction and compaction of mitochondrial 
genome 5. However recent genomics, proteomics and energy metabolism studies have 
suggested two endosymbiotic models for the origin of mitochondria. The first model 
“archezoan scenario” states, “the host of the proto-mitochondrial endosymbiont was 
amitochondrial eukaryote, termed archezoan” 6,7. The archezoan scenario is most closely 
related to the widely accepted endosymbiont hypothesis of mitochondrial origin 3,8. The 
second model “symbiogenesis scenario” states, “a single endosymbiotic event took place 
that involved the uptake of an a-proteobacterium by an archaeal cell leading to generation 
of mitochondria,” subsequently followed “by the evolution of the nucleus and 
compartmentalization of the eukaryotic cell” 6,7.The “hydrogen hypothesis” which is the 
best example of symbiogenesis scenario states that eukaryotes evolved “through 
symbiotic association of an anaerobic, strictly hydrogen-dependent, strictly autotrophic 
archaebacterium (the host) with a eubacterium (the symbiont) that was able to respire, but 
generated molecular hydrogen as a waste product of anaerobic heterotrophic metabolism. 
The host’s dependence upon molecular hydrogen produced by the symbiont is proposed 
to be the selective principle that forged the common ancestor of eukaryotic cells 6,9. This 
hydrogen hypothesis postulates that the origins of the eukaryotic lineage and that of the 
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symbiont are identical and the features of eukaryotic cell evolved after the symbiosis of 
the eubactieruim 6. Whereas archezoan scenario hypothesize that endosymbiosis of a-
proteobacterium giving rise to proto-mitochondrion happened after the formation of 
amtiochondriate eukarytic cell that served as the host. However the question still remains 
open regarding the nature of the cell that served as the host for the endosymbiont and 
evolved into mitochondria. With time more comparative genomics data will gradually 
refine the current ideas regarding the origin of eukaryotes and mitochondrial evolution. 
Mitochondria are known as intracellular “power plants” generating ATP for the 
sustenance of life. They form a dynamic network that is regulated by constant fusion and 
fission. A typical eukaryotic cell contains about 2000 mitochondria, which comprises 
about one fifth of its total volume 1.  
Mitochondria are characterized by two specialized membranes, the outer (OMM) and 
inner mitochondrial membrane (IMM) forming two compartments, the inter membrane 
space (IMS) and the mitochondrial matrix. The outer membrane is permeable to small 
molecules and ions that pass through transmembrane channels comprising of integral 
membrane proteins called porins. Larger molecules are brought across the outer 
membrane by the translocase of outer membrane (TOM).  The inner membrane is highly 
impermeable to H+ ions and this property of IMM forms the basis of mitochondrial 
energy transduction 10. Compounds, ions and molecules cross inner membrane through 
translocase of inner membrane (TIM). The inner membrane is further folded to form 
cristae (Latin for crest or plume) providing an increase amount of surface area harboring 
the respiratory complexes and the ATP synthase complex, which control the basic rates 
of cellular metabolism 1,10. The innermost space that is enclosed by inner membrane is 
known as mitochondrial matrix. Various metabolic processes like the b oxidation and 
tricarboxylic acid (TCA/Krebs cycle) take place in the mitochondrial matrix. In addition 
this compartment also contains several copies of mitochondrial genome (mtDNA), 
ribosomes, transfer RNAs (tRNAs), and various proteins and enzymes required for 
proper mitochondrial function. 
Mitochondria produces energy currency ATP by the oxidative phosphorylation system 
(OXPHOS) situated in the inner mitochondrial membrane. In addition to energy 
production, mitochondria are involved in various important processes such as the first 
step of iron-sulfur (Fe-S) cluster biosynthesis, b oxidation of fatty acids and biosynthesis 
of pyrimidines, amino acids, nucleotides, phospholipids and haem, regulation of cellular 
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metabolism, programmed cell death (apoptosis), calcium homeostasis and reactive 
oxygen species (ROS) formation. 
 
1.2. Mitochondrial Genetics 
Mitochondria are the only organelles besides nucleus that possess their own independent 
genome (mtDNA) located in mitochondrial matrix. Each somatic mammalian cell contain 
between 1000-10,000 copies of mtDNA. mtDNA molecules are packaged into DNA-
protein complexes known as nucleoids. Nucleoids contain essential maintenance proteins 
including the mitochondrial transcription factor A (TFAM) that plays an important role in 
mtDNA maintenance 11. Mammalian mtDNA is maternally inherited where mtDNA 
nucleoids represents the unit of inheritance. During mammalian zygote formation, sperm 
mitochondria are destroyed thereby blocking the transmission of paternal mtDNA 12. 
Inside the cytoplasm of the fertilized oocyte the sperm mitochondria are removed by 
ubiquitination and later subjected to proteolysis during preimplantation development 13. 
However there has been a single report of paternal transmission in humans thereby 
suggestion this block against transmission of paternal mtDNA can be bypassed 14.   
Human mtDNA is a circular double stranded molecule ~16.6 kb that encodes 13 essential 
polypeptides of oxidative phosphorylation system (OXPHOS) (Figure 1.1). In addition to 
mRNA molecules, the mitochondrial genome also encodes 2 ribosomal RNAs and 22 
transfer RNAs for translation of mtDNA transcripts (Figure 1.1). Around 1500 different 
proteins are required for the proper functioning of mitochondria, out of which ~ 90 
proteins are essential components of oxidative phosphorylation (OXPHOS) system. In 
addition nuclear encoded proteins are required for maintenance and expression of 
mtDNA. Hence it is evident that majority of the proteins are encoded by nuclear DNA 
(nDNA), synthesized in cytosol and imported into mitochondria by its specialized import 
machineries. Therefore a proper co ordination and communication is needed between the 
two genomes to maintain the homeostasis. The two strands of mtDNA are distinguished 
on the basis of their nucleotide composition that results in different densities in alkaline 
cesium chloride gradients. They are denoted as heavy strand (H) that is guanine rich and 
light strand (L), which is cytosine rich. mtDNA contains 37 genes, out of which the 
heavy (H) strand harbors 28 genes, 12 mRNAs, 2 rRNAs and 14 tRNAs whereas the light 
(L) strand harbors 9 genes, single polypeptide (ND6 subunit of Complex I) and 8 tRNAs 
(Figure 1.1). Mammalian mtDNA is extremely economic in terms of organization of its 
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genetic material that is densely packed with genes lacking introns. mtDNA contains only 
one major non coding region known as the displacement loop (D-loop) (Figure 1.1).  
 
 
Figure 1.1 Map of human mitochondrial DNA (mtDNA). 
 The two strands are denoted the heavy (H) and light (L) strand. The only noncoding region, the 
displacement loop (D loop) contains the promoters for transcription of the H and L strand (HSP 
and LSP) and the origin of replication of the leading strand of mtDNA (OH). The origin of 
replication of the lagging strand (OL) is located in a cluster of tRNA genes. Transcription from 
HSP produces 2 rRNAs (12S and 16S rRNA), 12 mRNAs (ND1–5, ND4L, Cyt b, COI–III, 
ATP6, and ATP8), and 14 tRNAs (F, V, L1, I, M, W, D, K, G, R, H, S1, L2, T). Transcription 
from LSP has a dual function. First, it produces RNA primers needed for initiation of replication 
at OH. Second, it is needed to produce 1 mRNA (ND6) and 8 tRNAs (P, E, S2, Y, C, N, A, Q) 15. 
 
Primers generated by transcription from LSP perform initiation of mtDNA replication at 
OH. However, this DNA replication often stops at the end of the D loop thereby resulting 
in a three-stranded structure containing a nascent H strand. This 1.1 kb control region is a 
short nucleic acid strand which is complementary to L strand and displaces H strand. The 
D-loop contains important regulatory elements of mtDNA expression such as the 
promoters for transcription of the L and H strands (LSP and HSP1) and the origin of 
replication of the H strand (OH) (Figure 1.1). 
 
1.3. Oxidative Phosphorylation (OXPHOS) system 
As stated earlier, one of the major functions of mitochondria is to generate energy in the 
form of ATP through a process called oxidative phosphorylation. The mitochondrial 
respiratory chain consists of five protein complexes (Complex I-V) that are embedded 
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into the lipid bilayer of the inner mitochondrial membrane (Figure 1.2). Out of the 92 
identified structural OXPHOS subunit genes, 79 are encoded by nuclear genome and 13 
are encoded by mtDNA genome which are the building blocks for the formation of the 
five OXPHOS complexes 12. The subunits of Complex I and Complex III-V are encoded 
by both nuclear DNA and mitochondrial DNA (mtDNA) whereas subunits of Complex II 
is exclusively encoded by nuclear genome. ATP is generated in a two-step process. In the 
first step electrons from NADH (reduced nicotinamide adenine dinucleotide) and FADH2 
(flavin adenine dinucleotide), produced by the oxidation of nutrients such as glucose and 
fatty acids, are passed along a series of carrier molecules called the electron transport 
chain to molecular oxygen to form water (Figure 1.2) 16. This generates an 
electrochemical gradient that allows Complex I, III and IV to pump protons across the 
inner membrane. This creates a proton gradient across the membrane, which is used by 
Complex V to produce ATP in the second step.  
Complex I or NADH dehrdrogenase (NADH: ubiquinone oxidoreductase) is the largest 
complex of the respiratory chain consisting of 44 subunits (14 core subunits - 7 from 
mtDNA and 7 from nDNA) and another 30 nDNA accessory subunits including a FMN-
containing flavoprotein and 6 iron-sulfur centers proposed to maintain the stability of the 
complex 10,12. Complex I is L-shaped comprising of a long and short arm. The long arm 
forms the hydrophobic integral membrane protein and the hydrophilic short arm contains 
the flavin mononucleotide (FMN) and the NADH active center extending into the matrix 
10. In this complex, oxidation of NADH allows the transfer of two electrons from NADH 
to FMN thereby reducing it to FMNH2. The electrons are further transferred to 
ubiquinone (Q) via iron sulfur cluster of Complex I. This electron transport is coupled 
with the transfer of four protons from mitochondrial matrix into the intermembrane space 
thereby creating the proton gradient (Figure 1.2). 
Complex II or succinate dehydrogenase (succinate: ubiquinone oxidoreductase) is the 
only complex consisting of 4 subunits that are encoded entirely by nDNA 12. This is 
another point where electrons can enter the electron transport chain besides Complex I. 
Complex II catalyzes the oxidation of succinate via flavin adenine dinucleotide (FAD) to 
form fumarate during which electrons travel from FADH2 through iron sulphur clusters to 
ubiquinone (Figure 1.2) 16.  
Ubiquinone is a lipid soluble benzoquinone that diffuses in the phospholipid bilayer of 
the inner membrane thereby assisting in shutting electrons between membrane proteins 
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(Figure 1.2) 10. 
Complex III or cytochrome bc1 (ubiquinol: cytochrome c oxidoreductase) is a complex 
comprising of 11 subunits; out of which 1 (cytochrome b) is encoded by mtDNA and 10 
are encoded by nDNA 12. This complex catalyzes the transfer of electrons from 
ubiquinols to cytochrome c that resulted in the translocation of four protons across the 
inner membrane (Figure 1.2) 16. 
Cytochrome c is a peripheral protein facing the intermembrane space and transfers 
electrons from complex III to complex IV (Figure 1.2) 10. 
Complex IV (cytochrome c oxidase) is the last enzyme of the electron transport chain 
consisting of 3 subunits encoded by mtDNA and 11 subunits encoded by nDNA 12. This 
complex transfers four electrons from reduced cytochrome c to O2 thereby producing two 
molecules of water. This electron transfer further resulted in the translocation of four 
protons across the inner membrane (Figure 1.2) 16.  
Complex V (F0F1-ATP synthase) consists of 19 subunits where 2 subunits are encoded 
by mtDNA and the remaining 17 subunits are encoded by nDNA 12. The electrochemical 
gradient is utilized by Complex V to drive the synthesis of ATP from ADP and Pi. 
Powered by the translocation of three protons into the mitochondrial matrix, Complex V 
synthesizes one molecule of ATP, which is the energy currency of cell that is finally 
transported outside mitochondria by adenine nucleotide translocase (ANT1) (Figure 1.2) 
16.  
 
 
 
Figure 1.2 OXPHOS system. 
Schematic representation of the OXPHOS system showing its individual components. The 
position of the matrix (M), the intermembrane space (IMS) and cristae or inner membrane (IM) 
has been indicated 17. 
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Two models have been proposed describing the supramolecular organization of these five 
complexes that together form the OXPHOS system. (i) The “fluid state” model postulates 
that the respiratory chain complexes diffuse freely in inner mitochondrial membrane and 
the electron transfer is based on random collisions of the single complexes 17,18. This is 
supported by the fact that all five complexes of the OXPHOS system can be purified to 
homogeneity in an enzymatically active form using isolated mitochondrial membranes 
17,19  
 
Figure 1.3 Model of the supramolecular structure of the OXPHOS system.  
Single complexes co-exist with supramolecular assemblies. Complex I (red) can associate with 
complex III2 (blue). Complex III2 can associate with one or two copies of complex IV (purple). 
The largest assemblies include complex I, dimeric complex III, and one or several copies of 
complex IV. (Yellow circles, ubiquinol, which either freely diffuses within the inner 
mitochondrial membrane or might form part of the I+III2 supercomplex. For simplicity, complex 
II was omitted from the figure because it is not known to form part of OXPHOS supercomplexes. 
Furthermore, cytochrome c, alternative oxidoreductases, and the ATP synthase complex are 
omitted from the figure) 19.  
.  
(ii) The “solid-state” model proposes stable interactions between the OXPHOS 
complexes within entities named supercomplexes or respirasomes 17. Several evidences 
has been reported in support of this model:(a) Supercomplexes including more than one 
type of OXPHOS complex are resolved by blue native polyacrylamide gel 
electrophoresis (BN-PAGE) and are shown to be active by in-gel activity experiments 
20,21; (b) Single particle electron microscopy studies revealed defined associations of 
OXPHOS complexes within the isolated respiratory supercomplexes 22,24; (c) Studies 
showed that point mutations in genes encoding one of the subunits of one OXPHOS 
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complex affect the stability of other OXPHOS complexes 25; (d) Flux control experiments 
indicate that respiratory chain operates as one functional unit 26,27; (e) Various 
reconstitution experiments  showed that different OXPHOS complexes when present at 
defined stoichiometries generated highest electron transfer activities 19;28; (f) Cardiolipin 
seems to assists the formation of some supercomplexes 29,30.  
Complex I, III, IV has been shown to form supercomplexes with defined stoichiometric 
composition (Figure 1.3). Electron microscopy studies have revealed interaction between 
complexes I and III, among complexes I, III and IV and in a dimeric form of complex V, 
between two ATP synthase monomers. The I+III2+IV1–2 supercomplex is known as 
respirasome that can autonomously carry out respiration in the presence of ubiquinone 
and cytochrome c (Figure 1.3) 17. Complex II in general, seems to maintain its singular 
state due to its direct involvement in the citric acid cycle and does not take part in 
formation of the respiratory chain supercomplexes 17. However one study reported 
Complex II containing supercomplexes 31.  
Although the debate on the membrane state of OXPHOS system is still ongoing, it is 
clear that many experimental observations cannot be explained only with “fluid state” 
model whereas other observations do not indicate only towards a “solid state” model. 
Hence this arise a possibility where the membrane state of OXPHOS system is of 
dynamic nature where respiratory supercomplexes may co-exist within the inner 
mitochondrial membrane with single OXPHOS complexes (Figure 1.3) 17,19. 
 
1.4. Replication of mtDNA  
mtDNA replication occurs randomly throughout the cell cycle and is independent of 
nuclear DNA replication. mtDNA replication machinery and proteins for maintaining its 
integrity are encoded by nuclear genome and subsequently imported into mitochondria. 
In eukaryotes, mtDNA replication takes place in a ‘replisome’ by mtDNA polymerase g 
(Pol g) which is a heterotrimeric protein consisting of a catalytic subunit (Pol g A) and a 
dimeric accessory subunit (Pol g B) (Figure 1.4). This heterotrimeric protein has three 
activities: DNA polymerase activity, 3’-5’ exonucleolytic proofreading activity and a 
5’dRP lyase activity that is required for enzymatic DNA repair 12. The additional 
components included in the replisome are mitochondrial single stranded binding protein 
(mtSSB) and TWINKLE which is a 5’-3’DNA helicase (Figure 1.4). Moreover 
mitochondrial transcription factor A (TFAM), RNA polymerase (POLRMT), RNA 
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processing enzymes (RNaseH1) and topoisomerase (mtTOP1) are required for the 
mtDNA replication. During mtDNA replication the TWINKLE helicase forms a hexamer 
that unwinds mtDNA in the 5’-3’direction facilitating mtDNA synthesis. The resulting 
single stranded region of mtDNA at replication fork is stabilized by mtSSB, which 
further stimulates the TWINKLE dependent mtDNA unwinding and enhancement of 
polymerase gamma activity (Figure 1.4) 12,13. POLRMT act as a primase to provide 
primers required for the initiation of lagging-strand DNA synthesis 15. RNaseH1 is 
involved in removing the short RNA primers required for the initiation of H and L strand 
DNA synthesis. mtTOP1 is proposed to have a role in relaxing negative supercoils and 
removing positive supercoils at the replication fork generated by DNA helicase 13. Finally 
TFAM plays a role in the maintenance of mtDNA integrity by actively participating in 
bending and packaging of mtDNA into nucleiods 32. 
 
Figure 1.4 The mtDNA replication machinery.  
The TWINKLE helicase has 5’to 3’directionality and unwinds the duplex DNA template. The 
mtSSB proteinstabilizes the unwound conformation and stimulates DNA synthesis by the POLγ 
holoenzyme 13. 
 
1.5.  Mitochondrial transcription 
mtDNA transcription generates the RNA primers for initiation of mtDNA replication at 
OH along with mtDNA expression. The principal mitochondrial transcription machinery 
consists of the mitochondrial RNA polymerase (POLRMT), mitochondrial transcription 
factor B2 (TFB2M), and mitochondrial transcription factor A (TFAM) 33. Recent studies 
have shown that TFB1M, which is a paralog of TFB2M, has no direct role in mtDNA 
transcription. However, TFB1M functions as a 12S rRNA methyltransferase that 
stabilizes the small subunit of the mitochondrial ribosome 34. Mitochondrial transcription 
is a bidirectional process that is initiated in the D-loop region where light-strand 
transcription starts from the light-strand promoter and heavy-strand transcription initiates 
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from two heavy strand promoters: HSP1 and HSP2 (Figure 1.1). TFAM is important for 
transcription initiation, as it preferentially binds the mtDNA upstream of the promoters 
thereby regulating RNA transcription. mtDNA transcription that is initiated from HSP1 
promoter terminates at the tRNALeu (UUR), thereby transcribing tRNAVal, tRNAPhe 
and 2 ribosomal RNA (12S and 16S) whereas transcription initiated from HSP2 promoter 
transcribes the full-length mtDNA 35. Moreover, mtDNA transcription that is initiated 
from LSP promoter can either proceed through entire mtDNA or can terminate 
prematurely to prime mtDNA replication. There are additional factors that modulate the 
activity of basal mitochondrial transcription machinery thereby affecting both 
transcription initiation and termination. POLRMT plays a role in elongation of 
transcription, which is also enhanced by mitochondrial transcription elongation factor 
(TEFM) 12. Termination of both H and L strand transcription has been proposed to be 
carried out by the mitochondrial transcription termination factor 1 (MTERF1) that binds 
downstream of the rRNA genes 12,15,36. In mammals, there is a family of four MTERF 
proteins (MTERF1–4) 15,37, where MTERF1-3 has been proposed to bind to the promoter 
region thereby modulating mtDNA transcription 35. Recent studies have shown different 
roles of the MTERF family proteins: MTERF2 has been shown to regulate oxidative 
phosphorylation by modulating mtDNA transcription 38. MTERF3 is shown to be a 
negative regulator of mtDNA transcription 39 and also plays a role in regulating 
mitochondrial ribosome biogenesis 40. MTERF4 is reported to regulate mitochondrial 
translation and ribosomal biogenesis by targeting RNA methyltransferase NSUN4 to the 
large ribosomal subunit 41. 
 
1.6. Mitochondrial translation 
Mitochondrial protein synthesis is an important process for all mammals since it produces 
thirteen polypeptides that are key components of the OXPHOS complexes. Despite of a 
50-year period of research where many factors critical for mitochondrial translation have 
been identified, the molecular details underlying the mitochondrial translation process 
remains incomplete. One of the major reasons behind this is the absence of an in vitro 
reconstituted system established from mammalian mitochondria that is capable of correct 
initiation and synthesis of a mitochondrial encoded protein. However studies in the past 
years have provided valuable information on specific features of mammalian 
mitochondrial protein synthesis where a number of the individual steps of protein 
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synthesis have been successfully carried out in vitro. Mitochondrial ribosome or 
mitoribosome is the key component of the mitochondrial protein synthesis process. 
Studies have shown that mammals possess a distinct set of ribosomes which sediment as 
55S particles and comprise 2 subunits, a 28S small subunit (mt-SSU) and 39S large 
subunit (mt-LSU) 42,43. Only two rRNA species has been identified in each subunit of 
mammalian mitoribosomes, 12S rRNA in small subunits and 16S rRNA in large subunit. 
In addition, ribosomes may also carry a 5S rRNA has been reported 44. Mammalian 
mitoribosomes have lower sedimentation coefficient (55S) compared to prokaryotes 
(70S) and cytosolic (80S) counterparts. This is due to the change in protein to RNA ratio. 
For prokaryotes/eukaryotic cytosolic ribosomes the protein:RNA ratio is 1:2 whereas for 
mammalian mitoribosome it is 2:1 suggesting a relatively low RNA content thereby 
compensated by a  large number of mitoribosomal proteins, reviewed in 43. The small 
subunit comprises of 29 proteins out of which 14 are homologues of prokaryotic 
ribosomes whereas the large subunits is composed of 48 proteins and 28 of them are 
homologues of bacterial ribosomal proteins 45. There are four steps (phases) for the 
protein synthesis in mammalian mitochondria: Initiation, elongation, termination and 
ribosomal recycling. 
(i) Translation initiation of mammalian mitochondria: 
The translation initiation process of mammalian mitochondria is different from that in 
prokaryotes and eukaryotic cytoplasm. It is still unclear how the mitoribosomes are 
directed to the initiation codon since mitochondrial mRNAs are not capped and lack any 
upstream leader sequences 46. Till date only two mitochondrial initiation factors have 
been identified, mitochondrial initiation factor 2 (IF2mt) and mitochondrial initiation 
factor 3 (IF3mt). According to a recent study it was shown in vitro that with IF2mt and 
IF3mt it was possible to assemble an initiation complex on 55S mitoribosomes with fMet-
tRNA correctly positioned at the start codon of a mitochondrial mRNA 42. Based on 
various studies a current working model has been proposed for the initiation of 
translation (Figure 1.5). In the first step, IF3mt interacts with 55S ribosome thereby 
loosening the interaction between the two subunits, releasing the 39S subunit and 
forming a transient 28S:IF3mt complex in the second step (Figure 1.5). This is followed 
by the binding of IF2mt: GTP to the small subunit in the third step. In the fourth step, it 
has been shown that the mRNA feeds into the 28S subunit via an mRNA entrance gate 
(Figure 1.5) 47.   
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Figure 1.5 Model for the initiation phase of mitochondrial translation.  
In the current model for the initiation of protein synthesis, mitochondrial initiation factor 3 (IF3mt) 
actively dissociates 55S ribosomes, forming a transient [IF3mt:55S] complex (Step 1) and leading 
to the formation of an IF3mt:28S complex (Step 2). Mitochondrial initiation factor 2 (IF2mt) bound 
to GTP binds to the small subunit (Step 3), followed by the fMet-tRNA and mRNA (Step 4), 
although the exact order of binding is not clear. Once the 28S initiation complex has formed, the 
large subunit joins, and along with the hydrolysis of GTP to GDP, the initiation factors exit (Step 
5) leaving a 55S:fMet-tRNA:mRNA complex that is ready for the elongation phase of protein 
synthesis 42. 
 
After the first 17 nucleotides of mRNA enters the ribosome the 5’end of mRNA pauses at 
the P-site of the ribosome. During this time, inspection is carried out by 28S subunit at 
the 5’ end of mRNA for the start codon. At this time, IF2mt: GTP may promote the 
binding of fMet-tRNA to the ribosome. If correct start codon in present in the P-site of 
mitoribosomes, a stable 28S initiation complex is formed via the codon:anticodon 
interactions between the fMet-tRNA and the 5’AUG start codon (Figure 1.5). However, 
if the inspection fails, when fMet-tRNA binds without mRNA or mRNA lacks a proper 
5’ start codon, the mRNA slides through the small subunit and finally dissociates (Figure 
1.5). But once the inspection succeeds and 28S initiation complex is formed, the large 
subunit joins the complex followed by hydrolysis of GTP to GDP by IF2mt in the fifth 
step. The initiation factors are released and 55S:fMet-tRNA:mRNA complex is formed 
that is ready for the elongation phase of protein synthesis  (Figure 1.5) 42.   
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(ii) Translation elongation of mammalian mitochondria: 
Three mitochondrial elongation factors, EF-Gmt, EF-Tsmt and EF-Tumt are involved in the 
process of polypeptide chain elongation. This elongation phase in mammalian 
mitochondria has many similarities to the process in prokaryotes 48, as compared to 
initiation and termination phases. The tRNA containing the growing polypeptide chain is 
located in the P-site of the mitoribosome. In the first step, GTP bound elongation factor 
Tu (EF-Tumt) that is the active form, binds aminoacyl-tRNA (aa-tRNA) to form a ternary 
complex (EF-Tumt-GTP-aa-tRNA) and enters the A-site of mitoribosome (Figure 1.6) 42. 
In the second step, once the codon:anticodon interactions take place, the ternary complex 
is selected triggering the hydrolysis of GTP to GDP by EF-Tumt, thereby releasing EF-
Tumt-GDP from the ribosome.  
 
 
Figure 1.6 Model for the elongation phase of mitochondrial translation.  
The tRNA containing the growing polypeptide chain is located in the P-site of the ribosome. EF-
Tumt brings the aa-tRNA to the A-site of the ribosome (Step 1). In concert with the hydrolysis of 
GTP to GDP, EF-Tumt leaves the ribosome (Step 2). EF-Tsmt binds to EF-Tumt, displacing the 
GDP molecule and forming an EF-Tumt·EF-Tsmt complex (Step 3). A GTP molecule displaces 
EF-Tsmt, and an EF-Tumt:GTP complex is formed (Step 4) which can then bind another aa-tRNA 
reforming the ternary complex. The large ribosomal subunit catalyzes peptide bond formation and 
the growing polypeptide chain is transferred to the tRNA in the A-site of the ribosome (Step 5). 
EF-G1mt:GTP binds to the ribosome at the A-site (Step 6) and catalyzes translocation of the 
ribosome, moving the deacylated tRNA out of the P-site and the peptidyl-tRNA from the A-site 
to the P-site (Step 7). A new cycle of elongation can then begin 42. 
. 
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The third step follows the binding of Elongation factor Ts (EF-Tsmt) to EF-Tumt thus 
displacing GDP. Subsequently GTP molecule binds to EF-Tumt displacing EF-Tsmt and 
forming EF-Tumt:GTP complex in the fourth step. This can now bind to another aa-tRNA 
to form a ternary complex for the next round (Figure 1.6) 42. In Step 5, the large 
ribosomal subunit catalyzing the peptide bond formation and the growing polypeptide 
chain is transferred to the tRNA in the A-site of the mitoribosome thus leaving a 
deacylated tRNA in the P-site. In the next step (Step 6), another mitochondrial elongation 
factor G1 (EF-G1mt) binds to GTP, forming EF-G1mt:GTP that binds to A-site of 
ribosome. It has been reported that this binding catalyzes the translocation of 
mitoribosome in the final step (Step 7) thereby removing the deacylated tRNA from the 
P-site and moving the peptidyl-tRNA from A-site to P-site (Figure 1.6) 42. Cryo-EM 
studies of the mitochondrial ribosome suggested that mitoribosomes lacks E-site 47.  
(iii) Termination of translation and ribosome recycling of mammalian 
mitochondria: 
It has been shown that UAA and UAG serve as stop codons but these stop codons are not 
recognized by any so far identified release factors. According to a recent study, it has 
been suggested that they promote a −1 frameshift thereby moving a classical UAG codon 
into the A-site for termination 49. In the first step, when the termination codon UAA or 
UAG enters the A-site of mitoribsomes, it is recognized by mitochondrial release factor 
mtRF1a (Figure 1.7). In presence of GTP, mtRF1a binds to the A- site in the second step, 
thereby promoting the hydrolysis of the peptidyl-tRNA bond (by the peptidyl transferase 
center on the 39S subunit) and subsequent release of the completed polypeptide (Figure 
1.7) 42. However, the manner in which mtRF1a is released from the mitoribosome after 
the release of polypeptide is still elusive. In the next step (step 3) mitochondrial ribosome 
recycling factor (RRF1mt) binds to the A-site of the ribosome, which is then accompanied 
by binding of RRF2mt (EF-G2mt). This binding enhances the dissociation of ribosomal 
subunits and release of deacylated tRNA and mRNA in the fourth step (Figure 1.7). The 
dissociation of ribosomal subunits and its release is dependent on the combined action of 
RRF1mt and RRF2mt (EF-G2mt) 29,50,51. Following the release of RRF1mt and RRF2mt from 
the ribosomse in the final step the ribosome begins another round of protein synthesis 
(Figure1.7) 42. 
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Figure 1.7 Model for the termination and ribosome recycling phases of mitochondrial 
protein synthesis.  
As the termination codon (UAG here) enters the A-site of the ribosome, mtRF1a and GTP bind to 
the A-site (Step 1) and promote GTP-dependent hydrolysis and release of the polypeptide chain 
(Step 2). How mtRF1a is released from the ribosome is not known. RRF1mt binds to the A-site of 
the ribosome (Step 3) and is joined by RRF2mt (also termed EF-G2mt). These factors promote the 
dissociation of the ribosomal subunits and release of the deacylated tRNA and the mRNA (Step 
4). Following release of RRF1mt and RRF2mt (Step 5), the ribosome begins another round of 
protein synthesis 42. 
 
1.7. Mitochondrial quality control (MQC) 
Mitochondria are dynamic organelles possessing various essential biological roles in 
cellular physiology; hence to maintain a healthy mitochondrial population, several 
interdependent mechanisms exist, starting from the molecular, organellar to the cellular 
level. These conserved mechanisms known as mitochondrial quality control (MQC) 
maintains the mitochondrial homeostasis. There are several issues that impose significant 
challenges to proper mitochondrial function:  
(a) The first challenge for maintaining homeostasis is the generation of reactive oxygen 
species (ROS), a byproduct of oxidative phosphorylation. Accumulation of ROS can 
cause damage to mtDNA, oxidative modification to the mitochondrial proteins, leading to 
misfolding and aggregation thereby disrupting their native functions (Figure 1.8A).  
(b) The second problem arises from the bigenomic nature of the mitochondrial proteome  
(Figure 1.8B). Mitochondrial proteome comprises of almost 1500 proteins and majority 
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of proteins are encoded by nuclear genome, synthesized in the cytosol and imported into 
mitochondria through specific translocation machineries. According to recent studies, 
~500 proteins reside in the matrix 52, ~60 proteins in inter membrane space (IMS) 53,54 
and ~100 polypeptides located in the outer membrane (OM). But the inner membrane 
(IM) proteome is the most enriched consisting ~840 proteins that comprises the electron 
transport chain and F1 FO ATPase complexes (OXPHOS system) 55. Out of the 1500 
proteins, only 13 polypeptides that are subunits of the respiratory chain are encoded by 
the mitochondrial genome and needs to be assembled together with the nuclear encoded 
ones. This complex biogenesis pattern requires a coordinated expression and 
communication between the two genomes and proper sorting-folding and assembly of 
these polypeptides into right stoichiometric complexes within the IM. If there is a failure 
of coordination or perturbation in homeostasis especially under stress condition these 
newly synthesized proteins are at a risk to misfolding and aggregation. Therefore 
mitochondria have its own quality control team consisting of chaperones and proteolytic 
machineries that deal with such problems and thereby maintain integrity. 
 
Figure 1.8 Biochemical stresses that challenge normal mitochondrial function. 
(A) Stalling the high-energy electrons at respiratory complexes I and III leads to generation of 
superoxide anion which—either directly or via subsequent ROS radicals—can damage biological 
molecules like mtDNA and propel additional damage. The biogenesis of OXPHOS complexes 
requires tight coordination between synthesis and assembly of the mitochondrial- and nuclear-
coded proteins. (B) Polypeptides derived from the nuclear genome are translated on cytosolic 
ribosomes and imported in an unfolded state into the mitochondrion via presequence translocases 
of the outer (TOM) and inner (TIM) membranes. Imported polypeptides are inserted into the IM 
where they are joined with mitochondria-synthesized subunits. Mismatches in subunit 
stoichiometry can lead to accumulation of unfolded or unassembled proteins that can affect 
functional integrity of mitochondria. In addition, the electron transport chain units of OXPHOS 
contain redox-active cofactors poised for rapid electron exchange reactions. (C) When improperly 
assembled, these prosthetic groups can act as pro-oxidants through their inherent ability to 
generate ROS via Fenton-like reactions 55.  
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(c) The final threat comes from the multiple redox cofactors of electron transport chain 
(ETC) (Figure 1.8C). If these cofactors are not assembled properly, they may act as pro 
oxidants through their inherent ability to generate ROS via Fenton-like reactions, thereby 
further adding to the challenging biochemical environment 56,57. If these challenges are 
not taken care of properly, they may further distort protein homeostasis leading to 
progressive failure of the organelle 55. 
In order to cope up with the above-mentioned challenges, cells have evolved elaborate 
quality control mechanisms that engage at several levels depending on the extent of 
damage (Figure 1.9). The molecular level of MQC is the first line of defense that 
comprises of highly conserved molecular chaperones and energy dependent proteases 
distributed across the mitochondrial compartments and also cytosolic proteolytic systems 
like the ubiquitin–proteasome system (UPS), which associates with the OMM 55. The 
primary role of the chaperones is to ensure proper folding and assembly of mitochondrial 
proteins and that of proteases is to remove damaged proteins from the organelle 58. The 
second line of defense is provided by the fusion and fission events that mediate organellar 
dynamics and regulate even redistribution of mtDNA and proteome throughout the 
mitochondrial network (Figure 1.9). Fusion with neighboring healthy mitochondria helps 
in restoring the function of damaged mitcohondria. However if the mitochondria are 
severely damaged, then fusion is impaired resulting in fragmentation of mitochondria that 
are selectively removed by mitochondria-specific type of autophagy known as 
mitophagy. Occurrence of mitophagy inhibits the release of pro-apoptotic proteins from 
damaged mitochondria thereby suppressing apoptosis, which is the final line of defense at 
cellular level (Figure 1.9) 58. 
In last years, mitochondrial derived vesicles (MDV) carrying selected oxidized cargo and 
delivering to lysosomes, has been identified as a new pathway to MQC. This process has 
been shown to be independent of mitochondrial dynamics and mitophagy. One of the 
proposed roles is to remove segments of the mitochondrial membranes containing 
damaged, hard to dissociate protein complexes and/or reactive prosthetic groups 
reviewed in 55.   
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Figure 1.9 Quality control (QC) surveillance of mitochondria. 
Intraorganellar proteases exert QC and regulatory functions to maintain respiratory chain (RC) 
activity. The functionality of damaged mitochondria can be restored by fusion and content mixing 
within the mitochondrial network. Severely damaged mitochondria fragment and are removed by 
mitophagy or induce apoptosis by the release of pro-apoptotic proteins 58. 
  
1.7.1 MQC in the matrix: 
Protein regulation and quality control is tightly regulated in the mitochondrial matrix, 
which is the most protein dense region since it harbors the enzymes of TCA cycle and 
other metabolic enzymes along with translational machinery 59. Most of the proteins are 
synthesized in the cytosol and imported as unfolded polypeptides into mitochondria 
through the outer and inner membrane translocators (TOM and TIM23, respectively) in a 
membrane potential (ΔΨm) dependent manner (Figure 1.10). A team of chaperones and 
proteases are involved to ensure proper translocation of these pre-proteins followed by 
removal of the N-terminal MTS and folding into their native state. In the first stage, 
mtHsp70 and J-type co-chaperones participate in import of precursor proteins that later 
with help of Hsp60-Hsp10 chaperone system promote folding of the imported 
polypeptides (Figure 1.10) 55. mtHsp70 harbors diverse roles in mitochondrial matrix. 
mtHsp70 is recruited to TIM23 translocase and at the channel it functions in the multi-
subunit PAM (Presequence Translocase-Associated Motor) thereby interacting with the 
translocating polypeptides to drive their import through the channel into the matrix 60. At 
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the same time mtHsp70 transiently binds to the incoming new polypeptides and to the 
fully translocated polypeptides keeping them in a partially folded state thereby promoting 
its proper folding (the so-called holdase function) 58. The activity of mtHsp70 is 
coordinated by J-type co-chaperones (in the motor complex associated with the TIM23 
translocase or MDJ1 in the matrix) and the nucleotide exchange factor MGE1 55. In 
addition, mtHsp70 has also a significant role in the biogenesis of iron sulfur cluster in the 
matrix 60. After import, in the second step, two subunits of MPP processing 
metallopeptidase complex performs the proteolytic removal of the N-terminal MTS 
(Figure 1.10). After the removal of MTS, some proteins undergo further processing by 
mitochondrial intermediate peptidase (MIP/Oct1) that removes additional residues, 
reviewed in 55. Moreover, following the MTS removal, multiple matrix proteins are 
stabilized by additional intermediate cleaving aminopeptidase Icp55 by removing the 
single destabilizing N-terminal amino acid residue (Figure 1.10), reviewed in 55. This 
process is proposed to be similar to the N-end rule protein stabilization pathway in 
cytoplasm 61 however, the proteases involved in the degradation of destabilized 
polypeptides are not yet identified. The free peptides generated by the action of MPP or 
MIP is cleared by the mitochondrial presequence peptidase, Cym1/PreP. Additionally, 
this conserved metallopeptidase can also clear small  (up to 65 amino acid residues) 
unstructured oligopeptides thereby preventing accumulation that may impair 
mitochondrial integrity, reviewed in 55. In addition to mtHsp70, Hsp60 chaperonin 
consisting of both Hsp60 and Hsp10 subunits, assists a set of small soluble proteins to 
reach its functional state 58. Hsp60 assembles into large barrel/cage like structures with co 
chaperone Hsp10 and facilitates in the folding of partially folded polypeptides after their 
release from mtHsp70 (Figure 1.10). Moreover, Hsp78 (in yeast) a chaperone protein of 
Hsp100 family has been identified which is involved in dissolution of aggregated proteins 
upon heat stress 58.  
There are two highly conserved major AAA+ serine proteases in matrix, Lon/Pim1 and 
ClpXP that are involved in degradation of proteins that fail to fold or assemble in the 
matrix (Figure 1.10). Lon/Pim1 protease forms a large homooligomeric complex where 
each subunit contains ATPase and serine protease motifs. Lon is primarily involved in 
removing heat damaged and oxidatively damaged proteins, particularly iron–sulfur 
containing proteins such as aconitase, which are susceptible to oxidative damage 55,59. In 
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damage 59. Lon has an important role in regulating the stability and expression of mtDNA 
via proteolytic control of the abundance of mitochondrial transcription factor TFAM, 
reviewed in 55. Details about ClpXP are discussed in Section 1.8. 
 
 
Figure 1.10 MQC in the matrix. 
Multiple proteases and molecular chaperones regulate the matrix subproteome. The regulation 
involves control of protein maturation and accumulation and degradation of poly- and 
oligopeptides. Proper maturation of the precursor proteins transported via the TIM23 translocase 
complex requires removal of mitochondrial targeting sequence by MPP processing 
metallopeptidase complex and, in certain cases, additional stabilizing processing by intermediate 
peptidases MIP/Oct1 and Icp55. Resulting free targeting peptides, as well as other small 
oligopeptides, are removed by mitochondrial presequence peptidase Cym1/PreP. Subsequent 
protein folding is facilitated by Hsp family chaperones. Stress-damaged, misfolded, and/or 
aggregated proteins are recognized and cleaved by AAA+ proteases Lon/Pim1 and ClpXP. 
Peptides produced by these proteolytic events are either subjected to additional processing by 
oligopeptidases or extruded through ATP-binding cassette (ABC)-type transporters into the 
cytosol where they activate mitochondrial unfolded protein response (UPRmt) 55.  
 
1.7.2 MQC in the IMM: 
The mitochondrial IM is considered to be the most proteinaceous biological membrane 
since it houses a significant part of the mitochondrial proteome including the OXPHOS 
complexes and metabolite carriers 55,58. As 13 polypeptides of RC are encoded by 
mitochondrial genome, a balance between the synthesis of nuclear and mitochondrial-
encoded proteins is required. If the balance is disturbed it may accumulate unassembled 
subunits and assembly intermediates of RC. Hence one of the major challenges for 
mitochondrial protein homeostasis is to maintain proper assembly and function of the 
respiratory complexes. In addition, proteins residing in the IM are a prime target of 
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mitochondrial ROS. Therefore, there are various proteolytic systems in the IM that 
ensures proper removal of non-functional and damaged proteins 55,58. IM-bound IMP 
proteolytic complex comprising of 2 subunits plays a role in processing the Mgr2 subunit 
of TIM23 translocase thereby stabilizing Mgr2 and promoting TIM23 assembly (Figure 
1.12) 55. Two membrane embedded ATP dependent metalloprotease complexes, termed 
AAA proteases are the major factors providing the quality control of the IM (Figure 1.11 
& 1.12). The catalytic domain of m-AAA protease is exposed to the matrix (m-) side 
whereas i-AAA protease is active on the intermembrane space (i-) side of the membrane. 
AAA proteases are composed of subunits containing one or two transmembrane 
segments, an ATPase domain that is conserved throughout the AAA+ protein family of 
ATPases and a C-terminal Zn2+-dependent metalloprotease domain. The m-AAA 
protease forms a large hetero-hexameric complex comprising of Yta10/AFG3L2 and 
Yta12/SPG7/Paraplegin subunits in yeast and human mitochondria whereas homo-
oligomeric complex of m-AAA proteases comprising of AFG3L2 subunits can also be 
formed. Studies have shown that another subunit AFG3L1 that can substitute for 
AFG3L2 in rodents 62. The i-AAA protease is similar to m-AAA except the fact that it 
forms homo oligomeric complex comprising of 6 subunits of Yme1/YME1L peptidase 
(Figure 1.11& 1.12) 59. Unassembled and/or damaged sununits of OXPHOS complexes 
and nonnative membrane proteins are the known substrates of AAA proteases. Not only 
integral membrane proteins but also proteins peripheral to the IM like subunit 7 of ATP 
synthase are degraded by AAA protease. In addition to its role in quality control, m-AAA 
protease in involved in regulating the synthesis of respiratory chain subunits within 
mitochondria. Assembly of MrpL32, which is a subunit of large mitochondrial ribosome, 
into functional mitochondrial ribosomes, is dependent on the processing by m-AAA 
protease, thereby activating mitochondrial translation. Moreover, in yeast mitochondria, 
m-AAA protease is involved in the maturation of ROS scavenger cytochrome c 
peroxidase (Ccp1) in the intermembrane space thereby protecting against ROS damage 63. 
Pcp1/PARL member of rhomboid family of serine proteases is part of the quality control 
team of IM, mediating processing of various IM polypeptides including cytochrome c 
peroxidase Ccp1 (processed in conjunction with m-AAA protease) (Figure 1.12) 55. 
Prohibitins that form ring like structure comprising of Phb1 and Phb2 subunits has been 
shown to modulate the proteolysis by m-AAA proteases (Figure 1.11) 58. The i-AAA 
proteases exhibit vital roles in regulating IM’s integrity and dynamics via its proteolysis. 
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One example is the PRELI protein family members Ups1 and Ups2 that are involved in 
transport, synthesis, and accumulation of mitochondrial phospholipids, are regulated by 
the proteolytic activity of the i-AAA protease 55. Secondly, it has been shown that the 
biogenesis of short isoform of the optic atrophy 1 (OPA1) dynamin-related GTPase, 
which is central to mitochondrial dynamics and mtDNA maintenance is regulated by the 
i-AAA protease 64,65. It has been proposed that AAA proteases may cooperate with other 
proteases and adaptor like proteins. It has been shown that IM-associated peptidase 
Atp23 that is involved in maturation of the respiratory complex V 55 cooperates with the 
Yme1 proteolytic complex for the degradation of Ups1 (Figure 1.12) 66. Similarly, Mgr1 
and Mgr3 have been shown to possess adaptor like function facilitating the degradation 
of substrates by i-AAA protease in yeast mitochondria (Figure 1.11) 67,68. Additionally, 
Afg1/LACE1, which is a matrix AAA+ protein has been proposed to act as an adaptor or 
cooperating partner of m-AAA complex thereby enhancing the degradation of its 
substrates (Figure 1.12) 69. Oma1, a member of metallopeptidase family M48 is another 
protease in the IM that plays a role in quality control and has been shown to have 
overlapping function with m-AAA protease (Figure 1.11& 1.12) 69,70. Oma1 has been 
proposed to process the long isoform of OPA1 thereby promoting IM fragmentation and 
activating the subsequent MQC system under stress conditions 64,71. 
 
 
 
Figure 1.11 MQC in the IMM.  
Newly synthesized subunits of RC are inserted into the IM by an insertion machinery (OXA). 
Unassembled subunits and unfolded proteins are degraded by AAA proteases. Assembly partners 
of AAA proteases modulate proteolytic activities. Oma1 mediates processing of membrane 
proteins 58.  
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1.7.3 MQC in the IMS: 
Besides i-AAA protease, the protein quality control in the IMS is regulated by the high 
temperature requirement A2 serine protease (HtrA2/Omi/Ynm3). HtrA2/Omi is a 
homotrimer and the only protease found in the compartment that contains a PDZ-domain 
required for recognizing hydrophobic stretches of misfolded proteins (Figure 1.12) 55. 
Htr2A that is shown to be modulated via PARL-assisted processing and by PTEN-
induced putative kinase 1 (PINK1) dependent phosphorylation suggesting a possible role 
in regulation of mitophagy, reviewed in 55. In addition, it has been proposed that 
HtrA2/Omi plays a role in apoptosis. Upon activation of apoptosis, HtrA2/Omi is 
released from the mitochondria into the cytosol and is responsible for cleaving the 
inhibitors of apoptosis, reviewed in 58. Morever, Prd1/ Neurolysin which is an 
oligopeptidase localized in IMS has been shown to degrade cleaved presequences and 
small oligopeptides thereby preventing their accumulation in the IMS (Figure 1.12) 55. 
 
 
 
Figure 1.12 MQC in the IM and intermembrane space (IMS).  
Complexity of mitochondrial IM anticipates vastly efficient systems to maintain protein 
homeostasis. These include two tightly coordinated proteases matrix-facing AAA metalloprotease 
(m-AAA) and intermembrane space-facing AAA metalloprotease (i-AAA), which along with 
other regulatory functions recognize excessive, misassembled, and damaged subunits of 
OXPHOS complexes associated with the IM. Another IM protease complex Oma1, with m-AAA-
overlapping functions, is also proposed to play a major role in mitochondrial dynamics and 
homeostasis upon stress conditions. Rhomboid-like Pcp1/PARL protease is implicated in the 
intramembrane proteolysis of several IM proteins in yeast, whereas in mammalian cells, it also 
contributes to regulation of mitochondrial turnover. The IMS PMQC is less studied. In addition to 
the i-AAA, which exerts both proteolytic and chaperone functions toward IMS-localized proteins, 
the IMS subproteome appears to be regulated by oligopeptidase Prd1/Neurolysin and serine 
protease Ymn3/HtrA2 55. 
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1.7.4 MQC in the OMM: 
The ubiquitin protease degradation system (UPS) plays an important role in maintaining 
OM proteostasis where the proteins are modified by ubiquitination, extracted from the 
membrane and delivered to 26S proteasome for subsequent degradation in a process 
known as MAD (Figure 1.13) 59. Several mitochondrial ubiquitin ligases associated with 
the cytosolic side of OMM such as MITOL/MARCH-V, Mdm30, MULAN/MAPL and 
RNF185 55,59 have been identified so far. Similarly, another E3 ubiquitin ligase Parkin 
has been reported to ubiquitinate several OMM proteins thereby subjecting them to UPS 
mediated degradation 59. However Parkin has been shown to possess dual roles, one in 
UPS mediated protein degradation and the other in clearance of damaged mitochondria 
via autophagy termed as mitophagy (discussed in section 1.7.6).  
 
Figure 1.1.13 MQC in the OMM.  
In addition to interception of mitochondria-destined proteins en route, the UPS provides an 
additional level of OM PMQC. It removes misfolded, damaged, or surplus proteins in the OM via 
the MAD process. MAD involves ubiquitylation by E3 ubiquitin ligases that tag proteins to be 
degraded and extraction of the peptides by the AAA+ protein VCP/Cdc48/p97 complex, which is, 
in turn, recruited to the OM through several mechanisms, including targeting by stressresponsive 
factor Vms1 or PINK1-Parkin functional tandem. Several reports suggest that some IM proteins 
might also be subject of MAD. Another AAA+ protein Msp1/ATAD1 targets and removes tail-
anchored proteins mislocalized to the OM 55. 
 
Recent studies have discovered VCP/p97/Cdc48-associated mitochondria stress 
responsive 1 (Vms1) protein that is primarily involved in extracting ubiquitinated 
proteins from multimeric complexes for recycling or degradation by the proteasome, in 
addition to its involvement in other cellular processes (Figure 1.13) 72. In yeast 
mitochondria, AAA+ protein VCP/p97/Cdc48 translocates from cytosol to OMM under 
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stress conditions recruiting the Cdc48-Npl4 complex thereby providing an insight to the 
mechanistic understanding of MAD 55. Moreover, VCP/p97/Cdc48 recruitment to 
damaged mitochondria has been shown to be dependent on Parkin suggesting that the 
mitochondrial ubiquitin ligases are involved in regulating both the mitochondrial 
proteome and mitophagy 73. In addition, some recent findings have shown that proteins 
from all four different mitochondrial compartments were found to be ubiquitinated 
suggesting that the proteins may have retro translocated from their respective 
compartments to the OMM similar to the degradation of ER proteins via the ERAD 
pathway, reviewed in 59. Recently, another OMM associated AAA+ protein 
Msp1/ATAD1 has been identified that is involved in preventing accumulation of 
mislocalized ER-destined tail-anchored proteins in the OM, thereby maintaining proper 
mitochondrial function (Figure 1.13) 55. Msp1 has been proposed to be a part of the 
protein quality control team of mitochondria however it would be interesting to see if 
Msp1 is an independent part of the OMM quality control or an additional branch of 
MAD. 
1.7.5 Mitochondrial dynamics - fusion & fission: 
The fusion and fission of mitochondria is the first pathway of MQC at organellar level 
that comes into action when the molecular pathways get overloaded (Figure 1.9). 
Mitochondria undergo continuous fusion and fission events thereby mediating 
mitochondrial dynamics and facilitating the maintenance of mitochondrial function. 
Mitochondrial dynamics, by mixing or separation of contents, assists the even 
redistribution of mtDNA and proteome throughout the mitochondrial network, resulting 
in the dilution of damaged molecules and/or replenishment of depleted components in 
malfunctioning organelles 55. Fusion and fission machinery is tightly regulated and 
respond differentially to different degree of stress: lower degree of stress favors fusion of 
mitochondria whereas higher stress tends to activate fission. The fusion and fission of 
mitochondrial membranes are mediated by four dynamin-related GTPases: Mitofusin 1 
and Mitofusin 2 (MFN1 and MFN2) in the outer mitochondrial membrane and optic 
atrophy 1 (OPA1) in the inner mitochondrial membrane that controls the fusion event 
whereas the dynamin-related protein 1 (DRP1) triggers fission (Figure 1.14) 63,74. Fusion 
not only promotes content mixing between intact and dysfunctional mitochondria but also 
protects mitochondria from mitophagy thereby protecting cells against excessive 
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degradation. When the level of stress is higher and protection via fusion is not sufficient, 
fission event kicks in by removing the damaged organelles from the network. DRP1 that 
mediates mitochondrial fission forms a collar around the mitochondrion’s exterior and 
pinches it into two daughters (Figure 1.14) 44. Out of these two daughters the one with 
higher membrane potential will be a preferable candidate of undergoing fusion whereas 
the other will be eliminated by mitophagy. Hence fission plays an important role in the 
quality control since it not only allows segregating irreversibly damaged mitochondria 
away from healthy network but also increases the number of mitochondria in the cell 
before mitochondrial biogenesis or cellular division 55.  
 
Figure 1.14 Mitochondrial dynamics in mitochondrial quality control (MQC).  
Depicted is a simplified sketch showing the basic processes of mitochondrial fission and fusion 
(as exemplified by the yeast machinery, mammalian counterparts in parentheses) as well as their 
relation to mitophagy and the induction of apoptosis. The major fission factor is the small GTPase 
Dnm1 (Drp1), which interacts with other proteins to form a collar-like structure on the 
mitochondrial surface. Constriction of the Dnm1 collar severs the enclosed membranes and 
results in mitochondrial fission. The mitofusins Fzo1 (Mfn1, Mfn2) and Ugo1 are involved in the 
fusion of the outer membrane (OM). Subsequent fusion of the inner membrane is mediated by 
different Mgm1 (Opa1) isoforms. Mitochondrial dynamics, by the mixing and separation of 
contents, facilitate the maintenance of mitochondrial function 75.  
 
1.7.6 Mitochondrial autophagy (Mitophagy): 
Severely damaged and impaired mitochondria are eliminated from healthy mitochondrial 
network through a process called mitochondrial autophagy, or “mitophagy”. Mitophagy 
is a form of selective autophagy (‘self-eating’) where the damaged mitochondria are 
engulfed by an autophagosome thereby delivering to lysosome for degradation and the 
breakdown products are made available for metabolism (Figure 1.15.A). This mitophagy 
 27 
process of removing damaged mitochondria is considered as a highly specific MQC at 
organellar level (Figure 1.9). In mammalian system, two pathways regulating mitophagy 
has been characterized so far.  
(a) PINK1 and the E3 ubiquitin ligase Parkin are the key players regulating mammalian 
mitophagy. In healthy mitochondria, PINK1 is imported in the mitochondria and cleaved 
by MPP and PARL. Following disruption of membrane potential, PINK1 instead of being 
imported into the mitochondria, accumulates in the OMM thereby recruiting the E3 
ubiquitin ligase, Parkin (Figure 1.15.A), reviewed in 59. Once Parkin is recruited its 
initiates ubiquitination of the OMM proteins like Hexokinase I, VDAC1, MFN1/2, and 
Miro 59. Ubiquitination of MFN1/2 seems to be a prerequisite for promoting mitophagy. 
It is been proposed that during the degradation of these fusion proteins, Parkin may 
inhibit the refusion of damaged mitochondria to the healthy network thereby selecting the 
impaired one for mitophagy. The role of Miro has been shown to anchor mitochondria to 
the cytoskeleton and degradation of this protein results in the release of damaged 
mitochondria from the network of the healthy ones 76. There is little disagreement in 
general regarding how PINK1 recruits Parkin to mitochondria. On one hand it has been 
proposed that Parkin directly interacts with PINK1 in the OMM 73 whereas several 
studies has shown cooperation of PINK1 and Parkin by sharing substrates. However, 
further studies are required to know the exact process. Parkin mediated ubuiquitination of 
mitochondrial substrates act as a signal for autophagic degradation, that is followed by 
the binding of the ubiquitin-binding adaptor p62 to both ubiquitinated substrates via its 
ubiquitin associated domain (UBA) and to LC3 on the autophagosomal membrane 
(Figure 1.15.A). This binding connects the ubiquitin tagged mitochondria directly to 
autophagosomes for engulfment. Therefore PINk1/Parkin quality control system appears 
to regulate at multiple levels starting from promoting fusion by degrading fusion proteins 
followed by releasing impaired mitochondria from the healthy network with subsequent 
tagging of the mitochondria via ubiquitination and finally initiating the formation of 
autophagosomes for final degradation 59.  
(b) There is another system where proteins residing in the OMM can directly function as 
mitophagy receptors without the need for ubiquitination and adaptor proteins. The OMM 
proteins NIP3-like protein X (NIX; also known as BNIP3L) and BNIP3 can directly 
associate damaged mitochondria to autpohagosomes through molecular interactions with 
LC3 and gamma-aminobutyric acid receptor associated protein (GABARAP) on the 
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autophagosomes (Figure 1.15B). NIX contains WXXL-motif facing the cytosolic side 
that allows direct binding to LC3 and GABARAP thereby inducing mitophagy 59,77. 
Thus mitophagy seems to be regulated by the above-mentioned two pathways where 
under stress condition the PINK1/Parkin pathway may take the front seat for the 
clearance of damaged mitochondria and the Nix/BNIP3 pathway may be crucial for 
maintaining healthy mitochondria under baseline conditions. However there might be a 
crosstalk between these two pathways irrespective of their distinct functions 59. 
 
 
Figure 1.15 Mitochondrial Autophagy (mitophagy). 
(A) Upon loss of mitochondrial membrane potential, PINK1 accumulates on the OMM surface. 
PINK1 recruits Parkin, which ubiquitinates OMM proteins, thus inducing engulfment of the 
mitochondrion by the autophagosome through p62 and LC3. (B) Nix and BNIP3 function as 
autophagy receptors on mitochondria by binding to LC3 on the autophagosome. Both pathways 
result in the autophagic sequestration of the mitochondrion, fusion with a lysosome, and 
degradation of the organelle 59.  
 
1.7.7 Mitochondrial derived vesicles (MDV): 
When the degree of damage to mitochondria exceeds the capacity of chaperones and 
proteases, portion of damaged mitochondria are pinched off for degradation (Figure 
1.16). These vesicles known as mitochondria derived vesicles (MDVs) transport oxidized 
proteins to lysosomes for degradation 78. The MDVs bud off functionally respiring 
mitochondria under normal condition and increases under oxidative stress conditions and 
has been shown to be independent of mitochondrial dynamics and mitophagy 78,79. 
Though studies undergone have revealed that the cargo of these MDVs is highly selective 
depending on the type of oxidative stress, however it is still unclear why selected proteins 
are removed under specific oxidative stress 78. This new mechanism of MDVs may 
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provide as additional strategy to remove parts of damaged mitochondrial membranes 
containing hard to dissociate protein complexes that cannot be catabolized within 
mitochondria 55. Recently it has been reported the requirement of PINK1 and Parkin for 
the formation of these MDVs under oxidative stress (Figure 1.16) 80. Though the role of 
PINK1 and Parkin is well established in mitophagy however this appears to represent 
another mechanism of MQC at organellar level. 
 
 
Figure 1.16 Mitochondrial derived vesicles.  
Mitochondria-derived vesicles (MDVs), destined for lysosome, appear to represent yet another 
facet of organellar MQC. This mechanism allows selective removal of fragments of mitochondria 
without affecting the entire organelle. Reportedly, the MDVs contain oxidized cargo and lipids 
and their formation in mammalian cells depends on the function of PINK1 kinase and E3 
ubiquitin ligase Parkin. When mitochondrial damage overwhelms the aforementioned 
mechanisms, failing organelles are segregated and targeted to autophagosomes, and subsequently 
to lysosomes where their content is degraded. The PINK1-Parkin functional tandem and UPS 
play important roles in the initiation of this process known as mitophagy 55. 
 
1.7.8 Apoptosis: 
When the load of the damage exceeds the capacity of candidates involved at molecular 
and organellar level, then quality control takes place at cellular level (Figure 1.9). There 
are two major pathways of apoptosis: extrinsic and intrinsic pathways responding to 
different stress induced signals or death stimuli. The intrinsic pathway of apoptosis is also 
known as the mitochondrial pathways due to the involvement of mitochondria that 
responds to different stimuli such as chemotherapeutic agents, serum starvation, 
irradiation and DNA damage (Figure 1.17) 81. Mitochondria plays a key role since it is 
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not only the site for interaction of various anti-apoptotic and pro-apoptotic proteins 
determining the cell fate but also the site where the initiation of signals regarding the 
activation of caspases takes place.  
 
 
Figure 1.17 The role of mitochondria in apoptosis. 
In healthy cells of vertebrates, Apaf-1 is in an auto-inhibited form and any basally processed 
caspase-9 and caspase-3/7 are bound by XIAP and hence, remain inactive. Upon apoptotic 
signaling, BH3-only proteins are either upregulated transcriptionally or activated through post-
translational modification. They then bind to antiapoptotic Bcl-2 proteins to remove their 
inhibitory effect or activate Bax/Bak directly. Protein-lipid interaction might also be involved in 
Bax/Bak activation, which leads to their oligomerization and triggers release of Cyt c, 
Smac/DIABLO, endoG, AIF, and Omi/HtrA2. Cytosolic Cyt c then binds to Apaf-1 to induce 
apoptosome formation, leading to caspase-9 and caspase-3/7 activation. Smac/DIABLO and 
Omi/HtrA2 bind to XIAP to remove its inhibitory effect. Ortholog proteins in different species 
are labeled in the same color 81,82. 
 
Whenever there is acute stress in the mitochondria the signals get transduced via one or 
more members of BH3-only subfamily of the pro-apoptotic Bcl-2 proteins that interacts 
with Bax subfamily of pro-apoptotic Bcl-2 proteins (Figure 1.17) 83. This results in the 
formation of mitochondrial outer membrane permeabilization (MOMP) thereby releasing 
intermembrane proteins into the cytosol that will initiate apoptosis. Once cytochrome c 
(Cyt c) is released to the cytosol it binds to apoptotic protease activating factor 1 
(APAF1) thereby initiating the formation of apoptosome. The apoptosome complex 
recruits and activates caspase-9, which in turn activates procaspase-3 (Figure 1.17). The 
activated caspase-3 along with other executioner caspases such as caspase-7 interacts 
with key death substrates thereby causing apoptosis. The apoptosis through mitochondria 
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can be inhibited at different levels by anti-apoptotic proteins such as anti-apoptotic BCL2 
family members BCL2 and BCL-XL and inhibitors of apoptosis proteins (IAPs). IAPs 
such as XIAP can bind to the activated caspase-9 thereby preventing its action on 
procaspase-3 (Figure 1.17) 83. Therefore, second mitochondria-derived activator of 
caspase/ direct IAP binding protein with low pI (Smac/DIABLO) and Omi binds to XIAP 
thereby prohibiting their inhibitory effects on caspase activity and apoptosis can proceed 
(Figure 1.17) 81. The involvement of anti-apoptotic proteins at different levels depicts a 
robust mechanism to prevent unnecessary activation of apoptosis in healthy cells.  
 
1.8. CLPXP: 
In order to perform mechanical work, AAA+ enzymes (ATPases associated with various 
cellular activities) utilizes the energy of ATP binding and hydrolysis to drive many 
biological processes 84,85. CLPXP is one of the major AAA+ protease of the 
mitochondrial quality control located in the mitochondrial matrix that utilizes the energy 
of ATP binding and hydrolysis to carry out protein degradation within mitochondria. 
Most of the studies have been carried out extensively in prokaryotes especially in E. coli 
where we gained knowledge about ClpP structure, its specific substrates and its function. 
ClpXP is a build up of two proteins, hexamers of an AAA+ ATPase called ClpX and 
heptamers serine protease called ClpP. The ClpXP protease forms a hetero-oligomeric 
complex comprising of two hexameric rings of ClpX and two stacks of ClpP heptamers 
(Figure 1.18) 85. EM studies have shown that the hexameric rings of ClpX may stack 
coaxially onto one or both ends of the ClpP tetradecameric barrel thereby forming a 
singly or doubly capped structures 86. Under the circumstances when doubly capped 
ClpX6•ClpP14•ClpX6 complexes have formed, translocation at any given time appears to 
occur from only one of the two ClpX rings indicating a proper coordination of the 
activities of ClpX is required through ClpP 85. ClpX possess various biochemical 
functions such as binding the substrates, adaptors and ClpP. ClpX component participates 
in recognizing short unstructured peptide sequences called degradation tags, degrons, or 
recognition signals in the protein substrates, unfolding the stable tertiary structure of the 
substrate and then translocating the unfolded polypeptide chain into the proteolytic 
compartment of ClpP for degradation.  
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Figure 1.18 Cartoon model of substrate recognition and degradation by the ClpXP 
protease.  
In an initial recognition step, a peptide tag in a protein substrate binds in the axial pore of the 
ClpX hexamer. In subsequent ATP-dependent steps, ClpX unfolds the substrate and translocates 
the unfolded polypeptide into the degradation chamber of ClpP for proteolysis, where it is 
cleaved into small peptide fragments 85. 
 
This degradation tags or degrons in the protein targets are essential since they facilitate 
recognition and delivery to ClpXP for degradation. This unfolding and translocation 
process is entirely dependent on ATP binding and hydrolysis to power the changes in the 
enzyme conformation thereby driving the mechanical processes (Figure 1.18) 85. The 
only function of ClpP is to serve as the proteolytic component of AAA+ proteases 
thereby cleaving any polypeptide chain that is being translocated into its chamber. The 
resulting peptides generated after cleavage are small enough to exit the chamber and be 
further degraded by exopeptidases to free amino acids. The proteolytic active sides of 
ClpP reside within a barrel shaped chamber that is formed by face-to-face stacking of two 
heptameric rings of ClpP 85. Each of the 14 subunits of ClpP contains a serine active site 
for complete peptide hydrolysis with a classical Ser, Asp, His catalytic triad. Orthologs of 
ClpP are present throughout eubacteria, choloroplasts and mitochondria of many 
eukaryotic cells in its active form, which is a double-ring tetradecamer 87. ClpP in its free 
state cannot degrade proteins longer than six amino acids 88. 
Protein degradation by ClpXP is a vital cellular process that maintains protein 
homeostasis in various ways by removing damaged, misfolded or unassembled proteins. 
In addition to general protein quality control, ClpXP also contributes to stress adaptation, 
DNA damage repair, phage replication, and cell division. Studies have identified 
substrates of ClpXP in E. coli that were trapped in a ClpX dependent manner with a 
mutation of an active site in ClpP 89. The substrates identified belong to a wide range 
including transcription factors, proteins involved in starvation and oxidative stress 
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response and metabolic enzymes. In addition to its general role in protein quality control, 
in E. coli it seems ClpXP also possess regulatory roles. One example is regulating the 
activity of transcription factors SigmaS and SigmaE involved in general and envelope 
stress responses thereby activating two-compartment specific stress response pathways 90. 
In general stress response, the cellular concentration of SigmaS is regulated by ClpXP 
mediated degradation along with the adaptor protein regulator of SigmaS protein B 
(RssB) 91. Due to its constant degradation by ClpXP, under normal conditions the cellular 
concentration of SigmaS is low. But under stress conditions, specific inhibitors of RssB 
(known as antiadaptors) prevents RssB mediated degradation thereby upregulating the 
transcription of SigmaS regulon 92–95. In this case ClpXP acts as a negative regulator of 
the response whereas in the envelope stress response its acts as a positive regulator 
activating transcription of SigmaE regulon 90. Another example is regulating the levels of 
RecN, which is a DNA damage repair protein that comprises an AA-COOH degron that 
is targeted to ClpXP for constitutive degradation 89. When damage to DNA occurs, it 
induces the SOS transcriptional response thereby increasing the synthesis of recN mRNA 
and protein which starts to accumulate irrespective of their constant degradation by 
ClpXP 85. Once the DNA damage induced SOS transcription slows down or stops, the 
levels of RecN in the cells become low due to degradation by ClpXP. In E. coli, ClpXP 
plays a very specific role in the quality control of protein synthesis. In case of stalled 
ribosomes during protein synthesis in E.coli, the ssrA tag is added to C-terminus of the 
incomplete nascent polypeptide chain by the tmRNA system. Th ssrA tags are recognized 
and degraded by ClpXP, reviewed in 85. This ssrA tag consistis of 11 residues, but in 
order to be recognized by ClpX just two C-terminal alanines and the negatively charged α 
–carboxyl group (AA-COOH) are needed 96. Other residues of the ssrA tag mediate 
binding of ClpXP adaptor protein stringent starvation protein B (SspB) that further 
accelerates the degradation of these ssrA tagged polypeptide chains 96,97.   
Orthologs of ClpX and ClpP are present in most bacteria, mitochondria and chloroplasts. 
Hence it is involved in diverse roles in various organisms. In E. coli, lack of ClpP results 
in delayed recovery both from stationary phase and following a shift to nutrient poor 
media 98. In Bacillus subtilis, ClpP has been shown to be involved in development of 
competence, motility, growth at high temperature and sporulation 99. In Caulobacter 
crescentus ClpXP has been shown to be important for viability and cell cycle progression 
100. ClpP is essential for stress tolerance and biofilm formation in Actinobacillus 
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pleuropneumoniae 101 and virulence in many bacterial pathogens including 
Staphylococcus aureus, Streptococcus pneumonia, Salmonella typhimurium. In 
Podospora anserine, deletion of ClpP leads to an increase in lifespan of the fungus 
including a healthy phenotype 75. In C. elegans, ClpXP has been shown to mediate the 
signals for unfolded protein response (UPRmt) 102,103. When the levels of unfolded 
proteins exceeds the amount of available chaperones then ClpXP mediates the 
degradation of these polypeptides into small peptides that are effluxed out of the 
mitochondria via the ABC transporter HAF-1 which then translocate activating 
transcription factor associated with stress-1 (ATFS-1) to the nucleus which further 
activates transcription of chaperones and proteases thereby restoring mitochondrial 
proteostasis 102–104. This proposed model is suitable to sense any imbalance between the 
proteins of nuclear and mitochondrial origin especially subunits of OXPHOS complexes. 
Later another study showed that ATFS-1 bearing a mitochondrial targeting sequence at 
its N-terminus is imported into the mitochondrial matrix and degraded by Lon protease 
under healthy condition. However under stress condition, import of ATFS-1 ceases and it 
gets accumulated in the cytosol. ATFS-1 also possesses a nuclear localization sequence 
(NLS) close to its bZip domain, which is then trafficked to the nucleus where it initiates 
the transcription response to cope up with the stress 104. In mammals, not much is known 
about the mechanism of UPRmt. There have been few studies carried out in cultured 
mammalian cells that showed upregulation of chaperones mainly HSP60, CLPP protease 
and the transcription factor CHOP (C/EBP homology protein), gave the first indication of 
existence of UPRmt 105,106.  Though the UPRmt is conserved among worms, mice and 
humans it is still unclear if the stress sensing and signaling mechanisms are identical to 
the ones identified in worms. Recent study has identified mutations in CLPP causing 
Perrault syndrome in humans that is characterized by sensorineural hearing loss and 
ovarian failure 107.  
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1.9. Objectives: 
There is relatively little knowledge regarding the biological role of CLPP and its specific 
substrates in mammals. Here we have generated Clpp conditional knockout mouse model 
in order to dissect the role of CLPP in mammalian mitochondria. With this model we 
aimed to analyze the consequences of absence of CLPP at physiological and molecular 
level. Moreover, since to date there are no studies regarding the specific substrates of 
CLPP in mammals, we aimed to identify its substrates. Substrates identification will 
allow us in understanding the role of CLPP in the affected molecular and biochemical 
processes
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2. Materials and Methods 
 
2.1 Mouse Experiments 
 
2.1.1 Animal Care 
Animal care was performed in accordance to the guidelines of the institutional animal 
care committee. All animal procedures were conducted in compliance with protocols, 
approved by local government authorities (Bezirksregierung Köln, Cologne, Germany) 
and were in accordance with NIH guidelines. Animals were housed in groups of 3 - 5 
mice per cage at an ambient temperature of 22 – 24 oC and kept at a 12-hour light / 12-
hour dark cycle. Animals were fed normal chow diet (NCD; Teklad Global Rodent 2018; 
Harlan) containing 53.5% carbohydrates, 18.5% protein, and 5.5% fat (12% of calories 
from fat) and drinking water. All animals had access to water and food, except 8 hours 
fasting prior to glucose tolerance test experiments. The animals were maintained in the 
pathogen-free animal facility of the CECAD. Mice were sacrificed by cervical 
dislocation. 
2.1.2 Mouse handling and breeding 
General mice handling and breeding was performed according to Silver (Silver, 1995). 
2.1.3 Mice- Genetic ablation of Clpp gene by homologous recombination 
Caseinolytic peptidase, ATP dependent proteolytic subunit (Clpp) gene targeting was 
carried out at Taconic Artemis, Germany, in Art B6/3.5 embryonic stem cell line on a 
genetic background of C57BL/6 NTac. LoxP sites flanked exons 3 to 5 of Clpp gene; 
positive selection marker (Puromycin resistance-PuroR) was inserted into intron 5 and 
was flanked by F3 sites. The targeted locus was transmitted through germline that 
resulted in heterozygous Clpp+/PuroR-loxP mice. These mice were bred with B6 Flp_deleter 
transgenic (TG) to remove the selection marker PuroR. Finally Clpp+/loxP mice were 
mated with mice expressing Cre recombinase under the promoter of beta-actin resulting 
in deletion of exons 3 to 5. This deletion finally resulted in loss of function of Clpp gene, 
by removing a part of the protease domain and generated a frameshift from exon 2 to 6. 
Clpp+/- heterozygous mice were intercrossed to obtain the Clpp-/- homozygous knockout 
mice. For all experiments, whole body Clpp deficient mice (homozygous knockout) and 
wildtype (control) littermates were used.  
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2.1.4 Body weight 
After weaning, animals were fed on normal chow diet (NCD). The body weight of each 
mouse was assessed weekly or biweekly from age 4-36 weeks.  
2.1.5 Analysis of body composition (NMR) 
Body fat content of live animals was measured using Nuclear Magnetic Resonance 
(NMR) analyzer minispeq mq7.5 (Bruker Optik, Ettlingen, Germany). 
2.1.6 Food intake and indirect calorimetry 
Daily food intake was calculated as the average intake of NCD from custom made food 
racks within the desired time frame. Mice were allowed to adapt to the food intake 
settings for minimum five days. Food intake measurements were performed for three 
consecutive days and the weight of the racks were determined on a daily basis.  
PhenoMaster System (TSE systems, Bad Homburg, Germany) was used for calorimetry 
measurements. This PhenoMaster system assessed metabolic performance and activity by 
an infrared light-beam frame (TSE systems).  Mice were placed in metabolic chambers 
(7.1 litre) for an initial training period of five days thereby allowing them to adapt to the 
single housing. During this time proper adjustments to drinking and feeding dispensers 
were recorded. The calorimetric analysis was performed at 22-24°C over a period of 48-
72 hours, which also recorded oxygen consumption, carbon dioxide production and 
locomotor activity (light barrier frame, TSE systems). Energy expenditure was measured 
via indirect calorimetric measurements. Food intake and indirect calorimetry 
experiemnets were performed with the help of Steffen Hermans and Jens Alber. 
2.1.7 Determination of blood glucose and lactate levels 
Tail bleeding of mice was performed as described (Silver, 1995). Glucose concentrations 
from venous blood, under fed and starved conditions were measured using glucose strips 
(Roche, Mannheim, Germany) with glucometer (ACCU-CHEK AVIVA, Roche, 
Mannheim, Germany). Similarly blood lactate levels under fed and starved conditions 
were measured using lactate strips with  (Roche, Mannheim, Germany). 
2.1.8 Glucose Tolerance Test 
For glucose tolerance test animals were fasted for approximately 8 hours with proper 
access to drinking water.  Blood glucose levels were measured using glucose strips with 
glucometer (ACCU-CHEK AVIVA, Roche, Mannheim, Germany) under fast condition 
(time point 0 min).  Then 20% glucose solution (1-2g/kg body weight) was given via 
intraperitoneal (IP) injection and blood glucose was measured at 15, 30, 60, and 120 
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minutes. To determine glucose tolerance, the mean blood glucose values for each group 
of mice were plotted versus time. 
2.1.9 Insulin Tolerance Test 
Insulin tolerance test was performed using random fed animals. After determining the 
basal glucose level, insulin (0.75 U/kg body weight; Insuman Rapid 40 IU/ml) was 
injected intraperitoneally.  Blood glucose was measured 15, 30, 45 and 60 minutes after 
injection. For assessing of insulin tolerance, blood glucose levels at each time point were 
calculated as percentage of its blood glucose levels at 0 minute (relative to basal glucose 
level) and then plotted versus time. 
2.1.10 Measurement of rectal body temperature 
Rectal body temperature was measured with the help of rectal thermometer (Bioseb 
Invivo Research Instrument) at two time points (time point o minute and 30 minutes) 
according to manufacturer’s instructions.  
 
2.2 Molecular Biology 
 
2.2.1 Isolation of genomic DNA from mice tails 
Mice tail biopsies were incubated overnight in lysis buffer (50 mM Tris-HCl pH 8.0, 2.5 
mM EDTA, 0.5% (w/v) SDS, 0.1 M NaCl, 10 mg/ml Proteinase K; Applichem GmbH, 
Darmstadt, Germany) in a thermoshaker (Eppendorf, Hamburg, Germany) at 55oC. DNA 
was precipitated by adding an equivalent volume of isopropanol (100%) and centrifuged 
at maximum speed for 20 minutes in a benchtop centrifuge (Eppendorf, Hamburg, 
Germany). The supernatant was removed and the pellet was washed with 70% (v/v) ice-
cold ethanol and further centrifuged at maximum speed for 15 minutes. Then, the 
supernatant was removed and the DNA pellet was air dried for 2-5 minutes and was 
resuspended in 50µl dH2O by shaking at 37 °C for 30 minutes.  
2.2.2  Isolation of genomic DNA from mice tissues 
A small piece of shock-frozen mice tissues (about 3 mm3) was taken and incubated (2-12 
hours) in lysis buffer (50 mM Tris-HCl pH 8.0, 2.5 mM EDTA, 0.5% (w/v) SDS, 0.1 M 
NaCl, 20 mg/ml Proteinase K; Applichem GmbH, Darmstadt, Germany) in a 
thermoshaker (Eppendorf, Hamburg, Germany) at 55oC, upto a speed of 900 rpm until 
the tissue dissolves. DNA was then precipitated by adding 75 µl of 8 M potassium acetate 
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and 0.5 ml chloroform, and centrifuging at maximum speed for 15 minutes in a benchtop 
centrifuge at 4oC. The upper aqueous phase, without disturbing the lower chloroform 
phase, was transferred to a new 1.5 ml eppendorf tube.  The tube was inverted several 
times after adding 1 ml of 95% ethanol (2 folds volume) to the samples where DNA gets 
visible. The samples were then centrifuged at maximum speed for 15 minutes at 4oC. The 
supernatant was removed and the pellet was then washed with ice-cold 70% (v/v) ethanol 
and centrifuged for an additional 5 minutes at 4oC. Afterwards, the samples were pulsed 
down and DNA pellets were resuspended in 100 µl ddH2O depending on the size of the 
pellet. The pellet was left overnight at 4oC allowing for complete dissolve. 
2.2.3 Isolation of total RNA from mice tissues 
Total RNA was isolated from mouse tissue using TRIzol reagent (Life Technologies 
GmbH, Darmstadt, Germany). 50-100 mg (3 mm3 tissue cube) tissues were dissected and 
transferred into Precellys (Bertin Technologies, Versailles, France) 1.5 ml tubes with 
beads. After adding 500µl of TRIzol reagent, the tissues were homogenized by a 
Precellys 24 (Bertin Technologies, Versailles, France) fast-prep machine at 5500 rpm for 
2x30 seconds. Afterwards, instructions from the manufacturers were followed. 
2.2.4 Quantification of nucleic acids 
DNA and RNA concentrations were measured by sample absorption at 260 nm and 280 
nm with a NanoDrop ND-1000 UV-Vis spectrophotometer (Peqlab, Erlangen, Germany). 
As an index of purity of DNA/RNA, a ratio greater than 2 of absorptions at 260 nm 
(DNA/RNA) divided by the absorption at 280 nm (protein) was used.  
2.2.5 Polymerase chain reaction (PCR) 
To detect whether the mouse genome contains wild type (+/+), floxed (loxP flanked) 
exons or full body knockout (-/-) and cre-recombinase gene (cre), PCR reactions were 
done with primers described in Table 2.1.  
Reactions were performed in a Verti Thermal Cycler (Applied Biosystems, Life 
Technologies GmbH, Darmstadt, Germany) in a total reaction volume of 20 µl. For wild 
type (+/+) and knockout (-/-) PCR, the following reagents were added to 1 µl of sample 
DNA; 11.55 µl of dH2O, 4 µl of 5x GoTaqBuffer (Promega), 1 µl of dNTPs (1.25 mM 
each), 0.8 µl of each primer (10 µM), and 0.05 µl of GoTaq (5 U/µl, Promega) For cre 
PCR, 10.5 µl of dH2O, 4 µl of 5x GoTaqBuffer, 3.2 µl of dNTPs (1.25 mM each), 0.6 µl 
of each primer (10 µM) and 0.1 µl of GoTaq (5 U/µl) were added to 1 µl of sample DNA. 
Bands were determined by visualization of PCR products using 2% agarose gel with 
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ethidium bromide or GelRed (Biotium, Hayward, CA). 
Table 2.1 Genotyping PCR primer sequences 
 
Primer Sequence 
Forward+/+ GTGGATGATGGTCAGTAGAATCC 
Reverse+/+ CCCAGACATGATTCCTAGCAC 
ForwardKO TGTGCATTCTTACCATAGTCTGC 
Forwardcre CACGACCAAGTGACAGCAAT 
Reversecre AGAGACGGAAATCCATCGCT 
 
PCR programs for wild type (+/+) and knockout (-/-) began with 5 minutes of 
denaturation at 95oC, followed by 28 cycles comprising of denaturation at 95oC for 30 
seconds, annealing at 60oC for 30 seconds and elongation at 72oC for 1 minute, and a 
final elongation step at 72oC for 10 minutes. 
PCR programs for cre PCR started with 5 minutes of denaturation at 95oC, followed by 
35 cycles consisting of denaturation at 95oC for 30 seconds, annealing at 53oC for 30 sec 
and elongation at 72oC for 30 sec, and a final elongation step at 72oC for 5 min. 
2.2.6 Southern blot analysis for mitochondrial DNA (mtDNA) quantification 
After DNA was isolated from mice tissues (as mentioned earlier), 5 µg DNA was 
digested by SacI restriction enzyme (New England Biolabs, Ipswich, USA) overnight at 
37oC. DNA was precipitated by addition of 10 µl 5M NaCl and 500 µl 95% EtOH (ice 
cold) to the digestions. The samples were mixed very well and then were placed at -80oC 
for 30 minutes. Next the samples were centrifuged at 14000 rpm for 15 minutes in a 
benchtop centrifuge at 4oC. After discarding the supernatant, the pellet was washed with 
1 ml 70% EtOH by centrifuging at 14000 rpm for 15 minutes at 4oC. The supernatant was 
removed, the pellet was air dried and dissolved in 20µl dH2O. After measuring the 
concentration of DNA (as mentioned before) 6 µl 6X DNA loading dye (Fermentas, St. 
Leon-Rot, Germany) was added to the DNA samples and were run on a 0.8% agarose gel 
with 5 µl PeqGreen, at 35V overnight. Next day, an image of the gel along with the 
ladder was captured in BioRad Universal Hood II. Then the gel was soaked in 0.2 M HCl 
for 10 minutes with gentle shaking followed by rinsing twice with dH2O. Further the gel 
was denatured in denaturation solution (1.5 M NaCl and 0.5 M NaOH) with gentle 
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shaking twice for 20 minutes. After rinsing shortly with dH2O, the gel was then 
neutralized with gentle shaking twice for 20 minutes in neutralization solution (1.5 M 
NaCl and 1 M Tris-HCl pH 7.5). After rinsing shortly with water again, the gel was 
blotted overnight. The blot was assembled by preparing a sandwich with two long, 
bridging Whatman papers -presoaked in 20X saline-sodium citrate (SSC) (3M NaCl and 
300 mM sodium citrate)-, two Whatman papers similar to the size of the gel (presoaked 
in 20X SSC), gel (surrounded tightly with plastic wrap to circumvent shortcuts), Hybond 
N+ nylon membrane (GE Healthcare, Munich, Germany), two Whatman papers similar to 
the size of the gel (presoaked in 20X SSC), about 10-15 cm of paper staple, glass plate 
and a weight of 500 g on top. After disassembling of the blot, the wells were marked with 
pen and the membrane was soaked for 2 minutes in 2X SSC solution (without shaking). 
Then the membrane was air dried for 10 minutes by placing them in between 2 Whatman 
papers. Finally the membrane was baked at 80oC for one hour and thirty minutes. 
Afterwards, the membrane was placed in a glass hybridization bottle and prehybridized in 
10 ml rapid-hyb buffer (GE Healthcare, Munich, Germany) for 60 minutes at 65oC. In the 
meantime, the probe, PAM1 – for the whole mouse mitochondrial genome- was labelled 
with Prime-It II Random Primer Labeling Kit (Agilent Technologies, Waldbronn, 
Germany) and α-32P-dCTP for 15 minutes. The probe was denatured at 99oC for 5 
minutes and was added to the glass hybridization bottle and hybridized for 2 hours at 
65oC. The membrane was then first washed in 2X SSC/0.1% SDS for 20 minutes at room 
temperature, then in 1X SSC/0.1% SDS for 20 minutes at 65°C and finally in 0.1X 
SSC/0.1% SDS for for 20 minutes at 65°C. The membrane was wrapped in a plastic bag 
and exposed to Amersham Hyperfilm (GE Healthcare, Munich, Germany) overnight. 
2.2.7 Northern blot analysis for mRNA, rRNA and tRNA levels 
After RNA was isolated (as mentioned earlier) and estimating the concentration of RNA, 
2 µg total RNA was taken and topped up with nuclease-free H2O to 10 µl. 10 µl RNA 
Loading dye (Sigma Aldrich, Seelze, Germany) was added to the samples and heated to 
70oC for 10 minutes. The agarose gel was prepared by adding 72 ml DEPC H2O to 1.2 g 
Agarose (Agarose-LE from Ambion, Life Technologies GmbH, Darmstadt, Germany).  
The mixture was heated up in the microwave till it dissolves followed by addition of 10 
ml of 10X MOPS Running Buffer (Ambion, Life Technologies GmbH, Darmstadt, 
Germany) and 18 ml farmaldehyde solution (Sigma Aldrich, Seelze, Germany). The gel 
solution was mixed well and poured to solidify. After loading the samples in the gel, it 
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was run in 1X MOPS Buffer for 2 hours at 130 V. The gel was visualized under UV and 
an image was taken with BioRad Universal Hood II. The gel was washed three times for 
15 minutes with clean, nuclease-free H2O and then soaked in 20X SSC solution for 20 
minutes. The gel was blotted overnight following the same sandwich technique 
mentioned in Southern blot analysis. After disassembling the blot, the wells were marked 
and the membrane was UV-crosslinked with Stratalinker UV Crosslinker (Agilent 
Technologies, Waldbronn, Germany) twice at 200000 Joule/cm2. The membrane was 
placed in a glass hybridization bottle and prehybridized in 10 ml rapid-hyb buffer (GE 
Healthcare, Munich, Germany) for 60 minutes at 65oC. Similar to Southern blot analysis, 
the probes for mitochondrial-encoded protein coding genes and ribosomal RNA were 
prepared with Prime-It II Random Primer Labeling Kit (Agilent Technologies, 
Waldbronn, Germany) and α-32P-dCTP. For preparation of tRNAs probes, 10 pmol of the 
probe was added to 2 µl of 10X T4 Polynucleotide Kinase Reaction Buffer (New 
England Biolabs, Ipswich, USA), 1 µl T4 Polynucleotide Kinase (New England Biolabs, 
Ipswich, USA), 12 µl dH2O and 20 µCi γ-32P-dATP. After the mixture was incubated at 
37oC for 90 minutes, the probe was added to the glass hybridization bottle and hybridized 
for 2 hours at 65oC (for mRNAs) or 42oC (for tRNAs). The membrane was washed firstly 
in 2X SSC/0.1% SDS for 20 minutes at room temperature, followed by washing in 2X 
SSC/0.1% SDS for 20 minutes at 65/42°C and finally in 0.2X SSC/0.1% SDS for 20 
minutes at 65/42 °C. The membrane was wrapped in a plastic bag and exposed to 
Amersham Hyperfilm (GE Healthcare, Munich, Germany) overnight. The probes 
mentioned in 39 are used for Northern blot analysis. 
2.2.8 Reverse transcriptase PCR (Gene expression analysis) 
RNA from tissues was isolated (as mentioned earlier) and the concentration was 
measured. In case of probes that didn’t span exon boundaries to quantify RNA expression 
of target genes, DNase digestion as performed. (DNA-free Kit, Ambion, Life 
Technologies GmbH, Darmstadt, Germany) 2 µg of RNA was reversely transcribed into 
cDNA using High capacity reverse transcription kit (Applied Biosystems, Life 
Technologies GmbH, Darmstadt, Germany). For quantitative real-time PCR, 50 ng of 
cDNA was amplified using Taqman Assay-on-Demand kits (Applied Biosystems, Life 
Technologies GmbH, Darmstadt, Germany; see Table 2.2). The only exceptions where 
Brilliant III Ultra-Fast SYBR Green QPCR Master Mix (Agilent Technologies, 
Waldbronn, Germany) was used are listed in Table 2.3. Real-time PCR analysis was 
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performed in ABIPRISM 7700 Sequence detector (Applied Biosystems, Life 
Technologies GmbH, Darmstadt, Germany). Relative expression of the target genes was 
adjusted for total RNA content by Hypoxanthine-guanine phosphoribosyltransferase 
(HPRT) or TATA-binding protein (TBP). Relative expression of mRNAs was determined 
using a comparative method (2−δδCT) according to the ABI Relative Quantification 
Method. 
Table 2.2 Probes used for quantitative real time PCR 
 
Gene Catalogue number 
Clpp Mm00489940_m1 
 
Clpx Mm00488586_m1 
 
Gfm1 Mm00506853_m1 
 
12S AJBJWSP 
 
16S Mm04260181_s1 
 
ATP6 Mm03649417-g1 
 
ND5 AIHSNT9 
 
COXIII Mm04225261_g1 
 
 
Table 2.3 SYBR Green probes used for quantitative real time PCR 
 
Gene Forward Reverse 
Eral1 GGACCGTATCCTTGGATTTTCTC GAGGACCCGTGGATTCTCAG 
p32 AGATCCAGAAACACAAGTCCCT CCTCCTCACCATCAAATGTTGG 
Pnpt1 AATCGGGCACTCAGCTATTTG CAGGTCTACAGTCACCGCTC 
Mrpp1 TGTCCTCCAAAGCACCTTCTT TGAATGCTCGACTTCATTGTAGC 
Trap1 CAGGACAGTTATACAGCACACAG CTCATGTTTGGAGACAGAACCC 
Hsp60 GCCTTAATGCTTCAAGGTGTAGA CCCCATCTTTTGTTACTTTGGGA 
Lonp1 ATGACCGTCCCGGATGTGT CCTCCACGATCTTGATAAAGCG 
Afg3l2 GTTGATGGGCAATACGTCTGG GACCCGGTTCTCCCCTTCT 
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2.3 Biochemistry 
 
2.3.1 Isolation of proteins from tissues 
Proteins were isolated from mice tissues by organ lysis buffer (50 mM HEPES, pH 7.4, 
1% Triton X-100, 100 mM NaF, 10 mM sodium orthovanadat, 10 mM EDTA, 0.2% 
SDS, 100 mM NaCl, dH2O and one tablet of protease inhibitor, EDTA-free (Roche, 
Mannheim, Germany). A piece of tissue, (around 3 mm3) added to Precellys (Bertin 
Technologies, Versailles, France) 1.5 ml tubes with beads containing 500 µl of organ 
lysis buffer. Homogenization was done using a Precellys 24 (Bertin Technologies, 
Versailles, France) fast-prep machine at 6500 rpm for 2x20 seconds with 30 seconds 
pause. Following disruption, the homogenate was incubated on ice for 10 minutes and 
centrifuged at 13000 rpm for 45 minutes at 4°C. The supernatant was transferred to a new 
tube and the concentration of proteins was measured using Bradford reagent (Sigma 
Aldrich, Seelze, Germany) following the manufacturer's instructions. Finally, the proteins 
were stored at -80 °C till further use. 
2.3.2 Isolation of mitochondria from tissues except skeletal muscle 
After sacrificing the mice, tissues were rinsed well to remove blood and then transferred 
into a 50 ml falcon tube containing 5 ml of mitochondria isolation buffer (MIB: 100 mM 
sucrose, 50 mM KCl, 1 mM EDTA, 20 mM TES, 0.2% BSA free from fatty acids, pH 
7.2). For heart, 1mg/ml of Subtilisin A was added and transferred into a glass 
homogenizer tube. The tissue was homogenized by Sartorius at 1000 rpm with 10-12   
strokes until the solution became homogeneous. The homogenate was transferred into 50 
ml Falcon tube with addition of 15 ml of MIB and centrifuged at 8500 g for 5 minutes at 
4°C. The supernatant comprising floating fat was discarded and the pellet was 
resuspended in 30 ml MIB by shaking. The samples were then centrifuged at 800 g for 5 
minutes at 4°C and the supernatant comprising mitochondria were transferred into new 
50 ml tube. To pellet mitochondria, the supernatant was finally centrifuged at 8500 g for 
5 minutes at 4°C. After discarding the supernatant the mitochondrial pellet was 
resuspended in 150 µl MIB without BSA. The concentration of mitochondria was 
measured using Bradford reagent (Sigma Aldrich, Seelze, Germany) following the 
manufacturer's instructions. 
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2.3.3 Isolation of mitochondria from skeletal muscle 
After sacrificing the mice, skeletal muscle tissue was dissected and placed in 10 ml of 
ice-cold PBS supplemented with 10 mM EDTA. After removing hairs/blood the tissues 
were transferred onto a petri dish and cut into small pieces. The pieces were resuspended 
in 15 ml of ice-cold PBS/10 mM EDTA with addition of 0.05% trypsin and transferred 
into a 50 ml Falcon tube. Following incubation on ice for 30 minutes, the samples were 
centrifuged at 200 g for 5 min at 4°C. The supernatant was discarded and the pellet 
comprising tissues was resuspended in IBM1 (67 mM Sucrose, 50 mM Tris-HCl pH 7.4, 
50 mM KCl, 10 mM EDTA, 0.2% BSA free from fatty acids, pH 7.4). The pieces were 
transferred to a glass homogenizer tube and homogenized by Sartorius at 1600 rpm with 
10 long strokes until the solution became homogeneous. The homogenate was transferred 
into 50 ml Falcon tube and centrifuged at 700 g for 10 minutes at 4°C. The supernatant 
was transferred into a new 50 ml tube and was centrifuged at 8000 g for 10 minutes at 
4°C to pellet mitochondria. After discarding the supernatant the mitochondrial pellet was 
resuspended in 5 ml of IBM2 (250 mM sucrose, 10 mM Tris-HCl, pH 7.4, 0.3 mM 
EGTA-Tris,). It was further centrifuged at 8000 g at 4°C for 10 minutes. The supernatant 
was discarded and the mitochondrial pellet was resuspended in 150 µl of IBM2. The 
concentration of mitochondria was measured using Bradford reagent (Sigma Aldrich, 
Seelze, Germany) following the manufacturer's instructions. 
2.3.4 Purification of mitochondria 
Mitochondria were isolated from heart as mentioned earlier. The final mitochondrial 
pellet was resuspended in 500 µl of 0.6 M sucrose. A gradient of 6 ml of 1.5 M sucrose 
and 6 ml of 1 M sucrose was prepared using 12.5 ml of ultracentrifuge tubes (Beckman 
Coulter). 500 µl of mitochondria was layered on top of the gradient and spun at 22,000 
rpm for 30 minutes at 4°C. After ultracentrifugation, mitochondria were collected from 
the interface of two different solutions of sucrose concentrations and five times the 
volume of solution buffer (10 mM Tris-HCl, pH 7.5; 5 mM EDTA) was added. After 
centrifuging it for 10 minutes at maximum speed on a benchtop centrifuge, the final 
purified mitochondrial pellet was stored at -80°C. 
2.3.5 Blue Native polyacrylamide gel electrophoresis (BN-PAGE) and in-gel 
activity of respiratory chain complexes I and IV 
BN-PAGE was performed according to the manufacturer’s specifications using the 
Novex Bis-Tris system (Life Technologies GmbH, Darmstadt, Germany). For 
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supercomplexes, 10% digitonin was used.  After the samples were transferred to PVDF 
membrane using wet transfer, immunodetection of mitochondrial protein complexes was 
performed. In-gel activity for Complex I was measured by incubating BN-PAGE gel in 
0.1 mg/ml NADH, 2.5 mg/ml nitrotetrazolium blue (NTB; Sigma-Aldrich, Seelze, 
Germany) and 5mM Tris (pH 7.4) for 1 hour. In-gel activity for Complex IV was 
measured by incubating BN-PAGE gel in 0.24 unit/ml catalase, 10% Cytochrome C and 
0.1% diaminobenzidine tetrahydrochloride (DAB; Sigma-Aldrich, Seelze, Germany) in 
50 mM Tris (pH 7.4) for 1 hour at 37°C.  
2.3.6 Western blot analysis 
Protein extracts from tissues were thawed and 40 µg of proteins was mixed in SDS-
PAGE sample buffer (2X Laemmli sample buffer: 4% SDS, 20% glycerol, 120 mM Tris-
HCl pH 6.8, 0.02% bromophenol blue and 200 mM DTT). The protein samples were 
boiled and separated by SDS PAGE (either using Tris-Glycine gels or Tris-HCl gels from 
Criterion from BioRad, California, USA). The protein samples were blotted to 
nitrocellulose membranes (GE Healthcare, Munich, Germany) using wet transfer method. 
Membranes were blocked in 5% Milk-PBST for 1 hour at room temperature and 
incubated overnight at 4°C in primary antibodies (Table 2.4) diluted in 5% Milk-PBST. 
After washing the membrane with PBST, 3 x 5 minutes, it was incubated for 1 hour at 
room temperature in secondary antibody after diluting in 5% Milk-PBST or 1X PBST (all 
secondary antibodies were from Sigma Aldrich, Seelze, Germany and the dilution used 
was 1:2000). The membrane was washed again 3 x 5 minutes with PBST and ECL 
solution (GE Healthcare, Munich, Germany) was added to the membrane to visualize the 
signals after exposing to Amersham Hyperfilm chemiluminescent film (GE Healthcare, 
Little Chalfont, UK). Films were developed in an automatic developer (Kodak, Stuttgart, 
Germany).  ImageJ software was used for western blot quantification as intensity per 
mm2.  
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Table 2.4 Primary antibodies used for Western blot  
 
Antigen Distributor Dilution 
AFG3L2 Polyclonal antisera made by Prof. Elena I. Rugarli 1:1000 
CLPP Sigma Aldrich, Seelze, Germany 1:1000 
CLPX Sigma Aldrich, Seelze, Germany 1:1000 
EF-TUmt Polyclonal made by Assistant Prof. Nono Tomita-Takeuchi 1:1000 
EF-G1mt Abcam (Cambridge, UK) 1:500 
ERAL1 Proteintech (Chicago, USA) 1:1000 
IF2-mt Polyclonal made by Prof. Aleksandra Filipovska 1:1000 
IF3-mt Polyclonal made by Prof. Aleksandra Filipovska 1:1000 
HSP60 StressMarq Biosciences (British Colombia, Canada) 1:1000 
LON Abcam (Cambridge, UK) 1:1000 
LRPPRC Agrisera (Sweden) 1:1000 
mtHSP70 Abcam (Cambridge, UK) 1:1000 
MRPL-12 Abcam (Cambridge, UK) 1:500 
MPRL-37 Sigma Aldrich, Seelze, Germany 1:1000 
MRPS-35 Proteintech (Chicago, USA) 1:1000 
MRPS-15 Polyclonal made by Prof. Dr. Nils-Göran Larsson 1:1000 
PNPT1 Proteintech (Chicago, USA) 1:1000 
P32 Millipore (Massachusetts, USA) 1:1000 
TRAP1 BD Bioscience (New Jersey, USA) 1:1000 
TOM20 Santa Cruz (Dallas, USA) 1:1000 
VDAC Abcam (Cambridge, UK) 1:1000 
ATP5a1 Mitosciences (Abcam, Cambridge, UK) 1:1000 
COXIV Invitrogen (Karlsruhe, Germany) 1:1000 
UQCRC2 Invitrogen (Karlsruhe, Germany) 1:1000 
SDHA Invitrogen (Karlsruhe, Germany) 1:10000 
NDUFA9 Invitrogen (Karlsruhe, Germany) 1:1000 
COX5B Invitrogen (Karlsruhe, Germany) 1:1000 
COXIII Invitrogen (Karlsruhe, Germany) 1:1000 
ACTIN Santa Cruz (Dallas, USA) 1:5000 
TUBULIN Sigma Aldrich, Seelze, Germany 1:1000 
 
2.3.7 Measurement of the respiratory chain complex activity  
The measurements of respiratory chain enzyme complex activities were performed 
according to 108.  
2.3.8 Measurement of the rate of oxygen consumption  
Measurement of oxygen consumption rates was performed with OROBOROS Oxygraph-
2k for high-resolution respirometry (Oroboros Instruments, Vienna, Austria) following 
substrate-uncoupler-inhibitor-titration (SUIT) protocol. First oxidative phosphorylation 
(OXPHOS) state for Complex I was measured with addition of substrates of Complex I 
(5 µl of 2 M pyruvate, 5 µl of 0.8 M malate and 10 µl of 2 M glutamate and 8 µl of 0.5 M 
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ADP) to 25 µg of mitochondria. Then substrate for Complex II (20 µl of 1 M succinate) 
was added to measure OXPHOS state for Complex I and II. Next, to evaluate 
mitochondrial coupling or state L respiration (oligomycin-inhibited LEAK respiration- 
state L), 1 µl of 4 mg/ml oligomycin was added that inhibited ATP synthase. This state L 
respiration is mainly caused by compensation for proton leak after inhibition of ATP 
synthase. Maximum respiration was achieved by a multiple-step FCCP titration (ETS- 
electron transfer system capacity state). Addition of FCCP reflected ETS capacity at un-
coupled respiration. Then Complex I was inhibited by 0.5 µl of 2 mM rotenone, to 
estimate the contribution of Complex II to the maximal ETS capacity. Finally 1 µl of 5 
mM antimycin A was added to analyze the residual oxygen consumption (ROX-state). 
2.3.9 Analysis of de novo transcription and translation in isolated mitochondria 
In organello transcription assay was performed as described earlier 39. Mitochondria were 
isolated (as mentioned before) and 1 mg of mitochondria was resuspended in incubation 
buffer (25 mM sucrose, 75 mM sorbitol, 100 mM KCl, 10 mM K2HPO4, 50 µM EDTA, 5 
mM MgCl2, 10 mM Tris-HCl pH 7.4, 1 mg/ml BSA, 1 mM ADP, 10 mM glutamate and 
2.5 mM malate,). 40 µCi of α-32P-UTP was added to the mitochondria and incubated for 
1 hour at 37 °C on rotary shaker for pulse. After incubation, samples were centrifuged at 
13,000 g for 2 minutes to remove unincorporated nucleotides. The pellet was washed 
twice with 1 ml of washing buffer (10% glycerol, 10 mM Tris-HCl pH 6.8 and 0.15 mM 
MgCl2) and resuspended in 1 ml of TRIzol reagent (Life Technologies GmbH, 
Darmstadt, Germany) for RNA isolation (as mentioned earlier). The RNA was further 
analyzed by Northern blotting (as mentioned earlier) and radiolabeled transcripts were 
visualized by autoradiography.  
In organello translation in mitochondria from heart and liver was performed as 
previously described 109. Skeletal muscle mitochondria were incubated in translation 
buffer containing 25 mM sucrose, 75 mM sorbitol, 100 mM KCl, 1 mM MgCl2, 0.05 mM 
EDTA, 10 mM Tris–HCl, 10 mM K2HPO4 pH 7.4, 1 mg/ml fatty acid‐free bovine serum 
albumin (BSA) with addition of 10 mM glutamate, 2.5 mM malate, 1 mM ADP.  In 
organello translation was performed for 1 hour with addition of 35S-met (0.25 mCi/ml) at 
37°C. After this period, 100 mM of non-radioactive methionine was added to the 
translation buffer to stop the protein synthesis reaction. The mitochondrial was washed 
twice with washing buffercontaining 5 mM of non-radioactive methionine. Finally the 
mitochondrial pellet was resuspended in translation buffer containing all amino acids, 
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including 60 µg/ml of methionine and cysteine that was divided into equal halves. First 
half of mitochondria were isolated by incubation in the SDS-PAGE loading buffer, while 
the other half was incubated for additional 3 hours for the “cold-chase” experiment. After 
3 hours the samples were processed similar to Pulse.  All the translation products from 
Pulse and Chase were separated by SDS-PAGE. The gels were stained with Coomassie 
Brilliant Blue R-250 (MERCK), then incubated in 5% glycerol and amplify solution (GE 
Healthcare, Munich, Germany) respectively. Finally the gel was dried and the newly 
synthesized polypeptides were detected by autoradiography.  
2.3.10 In cello translation in mouse embryonic fibroblasts (MEFs) 
In cello translation in MEFS was performed. In brief, cells were grown in a 100 mm plate 
and when the plate was 75-90% confluent, medium was removed and cells were washed 
twice with 5 ml of labeling medium (- Dulbecco’s modified Eagle’s medium, high 
glucose; cysteine and methionine free, 10 % dialyzed FBS, glutamine, sodium pyruvate). 
Meanwhile the labeling medium and normal growth medium (DMEM, high glucose; 10% 
FBS, glutamine and sodium pyruvate; Gibco Life Science, USA) were equilibrated to 37 
°C and 5% CO2. Next, 25 µl of emetine (Sigma), irreversible inhibitor of cytoplasmic 
translation was added to 5 ml of labelling medium and incubated for 5 minutes in the 
incubator.  70 µl of 35S methionine and cysteine mixture was added and incubated at 
37°C and 5% CO2 for 60 minutes (Pulse). After pulse labeling, the medium was removed 
and cells were incubated for 10 minutes in 5 ml of normal growth medium. After washing 
with PBS, cells were scarped with 1 ml of 1 mM EDTA/PBS and collected as pellet by 
centrifugation. The cells were further washed with PBS twice and then the final pellet 
was resuspended in 50 µl of solution containing PBS+ 1 mM PMSF. Protein 
concentration was measured with Bradford reagent (as mentioned earlier) and 50 µg of 
protein was finally resuspended in SDS PAGE sample loading buffer. 1 µl of benozonase 
(to remove nucleic acids from samples) was added and incubated at 37°C for 15 minutes. 
Finally the translation products from Pulse were separated by SDS-PAGE. Rest was 
followed similar to in organello translation. 
2.3.11 tRNA aminoacylation analysis 
For analysis of aminoacylation of tRNAs, total RNA was isolated with TRIzol reagent as 
mentioned before. RNA was resuspended in resuspension buffer consisting of 0.3 M 
NaOAc (pH 5.0) and 1 mM EDTA as described earlier110. To determine the levels of 
aminoacylation, 2 µg of acidic RNA was separated by acid-urea PAGE, consisting 6.5% 
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(19:1) polyacrylamide, 8 M urea gel in 0.1 M NaOAc (pH 5.0) buffer. Gels were run with 
30 mA for 48 hours at 4°C with frequent change of running buffer (0.1 M NaOAc, pH 
5.0). To measure the levels of deacylation, 2 µg of acidic RNA was incubated with 1M 
Tris pH 9.0 at 70°C for 10 minutes. tRNAs were finally detected using specific γ-32P-
dATP labeled oligonucleotide probes  as mentioned before 39.  
2.3.12 Analysis of mitoribosomes and RNA using sucrose density   
ultracentrifugation 
Sucrose density ultracentrifugation of mitochondrial ribosome was performed as 
described earlier 34. 0.9-1.0 mg of mitochondria were lysed in lysis buffer (260 mM 
sucrose, 100 mM KCl, 20 mM MgCl2, 10 mM Tris-HCl pH 7.5, 1% Triton X100, 0.08 
U/µl RNaseOUT™ Recombinant Ribonuclease Inhibitor (Invitrogen), supplemented with 
EDTA-free complete protease inhibitor cocktail (Roche). Next mitochondrial lysates 
were loaded on top of 10%-30% linear sucrose gradient comprising of 100 mM KCl, 20 
mM MgCl2, 10 mM Tris-HCl, pH 7.5 and EDTA-free complete protease inhibitor 
cocktail (Roche). rRNA and mRNA sedimentation profile was performed as described 
previously 111. RNA was isolated from one third of fraction collected, using Trizol®LS 
(Life Technologies GmbH, Darmstadt, Germany) according to manufacturer’s 
instructions. The samples were further subjected to DNase treatment (Ambion) and then 
reverse transcribed to cDNA using High-Capacity cDNA Archive kit (Applied 
Biosystems). To detect each mitochondrial transcripts, TaqMan gene expression assays 
were used (Applied Biosystems) as mentioned earlier. 
 
2.4 Cell culture  
 
2.4.1 Preparation of primary mouse embryonic fibroblasts and immortalization 
Primary MEFs were isolated from E13.5 days resulted from an intercross of Clpp 
heterozygous (+/-) mice as described earlier 112. Labeling was done accordingly: B1, B5, 
C2, C3, C6, C7, D5, D6, E5, F5, F8 for wild type; A5, A8, B8, C1, C9, D1, D7, E2, E4 
for knockouts.  Cells were grown in Dulbecco’s modified Eagle’s medium (DMEM) 
(4.5g/L glucose, with GlutaMAX/Glutamin and sodium pyruvate; Gibco Life Science, 
USA) supplemented with 10% FBS and 100 units/ml penicillin and 100 µg of 
Streptomycin. Cells were maintained at 37°C with 5% CO2. Immortalization of the 
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following primary MEFs B1, B5, C2 WT and A5, A8, B8 KO were carried out using 
plasmid encoding SV40 T antigen. 
2.4.2 Immunostaining 
Cells grown on cover slips over night were stained for mitochondria by incubation with 
MitoTrackerRed CMXRos (Invitrogen, Karlsruhe, Germany), (dilution 1:10,000 in 
cultivation medium - DMEM with Glutamax, 4.5 % (w/v) Glucose; Gibco Life Science, 
USA; 10 % (v/v) FCS, 50 µl/ ml Penicillin, 50 µg/ ml (w/v) Streptomycin) for 15 minutes 
at 37 °C, 5% CO2. After exchanging the staining medium with fresh cultivation medium, 
cells were incubated for additional 15 minutes in the incubator. For immunolabeling of 
DNA, cells were washed shortly with PBS and fixed with 4% formaldehyde solution in 
PBS for 20 minutes at room temperature (300 µl/cover slip). Cover slips were then 
washed twice for 5 minutes in PBS and cells were permeabilized by incubation with 
0.5 % (v/v) Triton X-100 in PBS for 5 minutes (300 µl/cover slip). After washing again 
the cover slips twice for 5 minutes in PBS, blocking of unspecific binding was done by 
incubation with 5 % (w/v) bovine serum albumin in PBS for 5 minutes (200 µl/cover 
slip).  Finally, immunodetection was carried with the primary monoclonal mouse 
antibody against DNA (dilution 1:100 in blocking solution) for 1hour at room 
temperature (150 µl antibody solution/cover slip).  Cover slips were washed twice with 
PBS for 5 minutes. The primary antibody was detected after incubation with secondary 
antibody IgM 488 (150 µl/cover slip, dilution 1: 400 in blocking solution) for 30 minutes. 
Cover slips were washed once with 0.5% Triton-X100 in PBS for 5 minutes (300 
µl/cover slip) and PBS for 10 minutes at room temperature. The samples were finally 
mounted with one drop MOWIOL with 2.5 µg/ ml DAPI (AppliChem, Darmstadt, 
Germany). Samples were further analysed using the confocal microscope Leica TCS SP5. 
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2.5  Computational analysis 
 
2.5.1 Software 
All graphical representations and figures were created using Microsoft Excel (Microsoft 
Corp., Redmond WA, USA), Adobe Illustrator CS4 (Adobe Systems, San Jose CA, USA) 
and Inkscape for Mac. This thesis was written using Micorosoft® Word 2011 for Mac. 
2.5.2 Statistical analysis 
Statistical calculations were done using Microsoft Excel (Microsoft Corp., Redmond 
WA, USA). To determine statistical significance, a two-tailed unpaired student’s t-test 
was used. The p values below 0.05 were considered significant. Error bars represent 
standard error of the mean (S.E.M.) *p<0.05; **p<0.01; ***p<0.001 compared to control 
(+/+). 
 
2.6 Chemicals and biological material 
Size markers for agarose gel electrophoresis (Gene Ruler DNA Ladder Mix) and for 
SDS-PAGE (Page Ruler Prestained Protein Ladder Mix) were from Fermentas, St. Leon-
Rot, Germany. GoTaq® Green Master Mix and DNA Polymerase were obtained from 
Promega, Mannheim, Germany. Chemicals used in this work are listed in table 2.5. 
Solutions were prepared with double distilled water. 
Table 2.5 Chemicals used and suppliers 
 
Chemical Supplier 
β-mercaptoethanol Applichem, Darmstadt, Germany 
2,2,2-Tribromoethanol (Avertin) Sigma-Aldrich, Seelze, Germany 
2-Methyl-2-Butanol Sigma-Aldrich, Seelze, Germany 
Acetic Acid Merck, Darmstadt, Germany 
Acetone KMF Laborchemie, Lohmar, Germany 
Acrylamide Roth, Karlsruhe, Germany 
Adenosine 5’-diphosphate 
monopotassium 
Sigma-Aldrich, Seelze, Germany 
Agarose Sigma-Aldrich, Seelze, Germany 
Agarose (Ultra Pure) Life Technologies, Darmstadt, Germany 
Ammonium Acetate Merck, Darmstadt, Germany 
Ammoniumpersulfat (APS) Sigma-Aldrich, Seelze, Germany 
Antimycin A Sigma-Aldrich, Seelze, Germany 
Bovine serum albumin (BSA) Sigma-Aldrich, Seelze, Germany 
Bromophenol Merck, Darmstadt, Germany 
Calcium Chloride Merck, Darmstadt, Germany 
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Chloroform Merck, Darmstadt, Germany 
DMEM Gibco Life Science, USA 
D-Sorbitol Applichem, Darmstadt, Germany 
Deoxynucleotides (dNTPs) Sigma-Aldrich, Seelze, Germany 
Dimethylsulfoxide (DMSO) Merck, Darmstadt, Germany 
di-Natriumhydrogenphosphate Merck, Darmstadt, Germany 
Dipotassium phosphate Sigma-Aldrich, Seelze, Germany 
Dithiothreitol Sigma-Aldrich, Seelze, Germany 
Enhanced chemiluminescence (ECL) GE Healthcare, Munich, Germany 
Ethanol, absolute Applichem, Darmstadt, Germany 
Ethidium bromide Sigma-Aldrich, Seelze, Germany 
Ethylendiamine tetraacetate (EDTA) Applichem, Darmstadt, Germany 
EGTA-Tris Applichem, Darmstadt, Germany 
FBS Gibco Life Science, USA 
FCCP Sigma-Aldrich, Seelze, Germany 
Formaldehyde solution Sigma-Aldrich, Seelze, Germany 
Formamide Applichem, Darmstadt, Germany 
Galactose Merck, Darmstadt, Germany 
Glucose Merck, Darmstadt, Germany 
Glycine Applichem, Darmstadt, Germany 
Glycerol Sigma-Aldrich, Seelze, Germany 
HEPES Applichem, Darmstadt, Germany 
Hydrochloric acid (37%) Applichem, Darmstadt, Germany 
Hydrogen peroxide Sigma-Aldrich, Seelze, Germany 
Isopropanol (2-propanol) Roth, Karlsruhe, Germany 
L-cysteine hydrochloride monohydrate Sigma-Aldrich, Seelze, Germany 
L-methionine Sigma-Aldrich, Seelze, Germany 
L-Glutamine Sigma-Aldrich, Seelze, Germany 
Oligomycin Sigma-Aldrich, Seelze, Germany 
MOPS Applichem, Darmstadt, Germany 
Magnesium chloride Merck, Darmstadt, Germany 
Methanol Roth, Karlsruhe, Germany 
Nitrogen (liquid) Linde, Pullach, Germany 
Non fat dried milk Applichem, Darmstadt, Germany 
Penicillin Gibco BRL, Eggenstein, Germany 
PonceauS Sigma-Aldrich, Seelze, Germany 
Potassium acetate Sigma-Aldrich, Seelze, Germany 
Paraformaldehyde (PFA) Sigma-Aldrich, Seelze, Germany 
Phenylmethylsulfonylfluoride (PMSF) Sigma-Aldrich, Seelze, Germany 
Phosphate buffered saline (PBS) Gibco BRL, Eggenstein, Germany 
Potassium chloride Merck, Darmstadt, Germany 
Potassium hydroxide Merck, Darmstadt, Germany 
Protease Inhibitor Cocktail Tablets Roche, Basel, Switzerland 
Rotenone Sigma-Aldrich, Seelze, Germany 
Sodium acetate Applichem, Darmstadt, Germany 
Sodium azide Sigma-Aldrich, Seelze, Germany 
Sodium chloride Applichem, Darmstadt, Germany 
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Sodium citrate Merck, Darmstadt, Germany 
Sodium dodecyl sulfate Applichem, Darmstadt, Germany 
Sodium fluoride Merck, Darmstadt, Germany 
Sodium hydroxide Applichem, Darmstadt, Germany 
Sodium pyruvate Sigma-Aldrich, Seelze, Germany 
Sodium orthovanadate Sigma-Aldrich, Seelze, Germany 
Streptomycin Gibco BRL, Eggenstein, Germany 
Sucrose Applichem, Darmstadt, Germany 
Tetramethylethylenediamine (TEMED) Sigma-Aldrich, Seelze, Germany 
TES Applichem, Darmstadt, Germany 
Trishydroxymethylaminomethane(Tris) Applichem, Darmstadt, Germany 
Triton X-100 Applichem, Darmstadt, Germany 
Tween 20 Applichem, Darmstadt, Germany 
Trypsin Gibco BRL, Eggenstein, Germany 
Urea Fluka Analytical, Seelze, Germany 
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3. Results 
 
3.1. Clpp (caseinolytic peptidase, ATP dependent proteolytic subunit) 
knockout mice are smaller than littermates and not born in Mendelian 
proportion   
To decipher the in vivo role of caseinolytic peptidase, ATP dependent proteolytic subunit 
(CLPP) in mammals and to elucidate the effects of CLPP deficiency at physiological and 
molecular levels, we have developed a conditional knockout allele for Clpp by 
homologous recombination in ES cells. Exons 3 to 5 of Clpp gene were flanked by loxP 
sites, allowing Cre-mediated recombination arising in deletion of Exons 3 to 5 that 
resulted in loss of function of Clpp gene, by removing a part of the protease domain and 
generated a frameshift from Exon 2 to 6 (Figure 3.1).  
 
Figure 3.1 Disruption of Clpp in the germline  
Targeting strategy for the generation of conditional and constitutive knockout Clpp alleles. 
PuroR-Puromycin resistance, positive selection marker; Arrows depicts PCR primers used for 
genotyping of the alleles. The position of the forward and reverse primers has been marked with 
arrows detecting the presence of wild type (+/+, control) and loxP allele. The forward knockout 
(FKO) will detect the knockout (Clpp-/-) allele. 
 
The targeting strategy was accomplished at Taconic Artemis. The targeted locus was 
transmitted through germline that resulted in heterozygous Clpp+/PuroR-loxP mice. These 
mice were crossed with mice expressing Flp recombinase to remove the selection marker 
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PuroR. The Clpp+/loxP mice were obtained from Taconic Artemis, which were finally 
mated with mice expressing Cre recombinase under the promoter of beta-actin that 
resulted the Clpp+/- heterozygous mice. Clpp+/- heterozygous mice were intercrossed to 
obtain the Clpp-/- homozygous knockout mice (Figure 3.1).  
The homozygous knockout mice (Clpp-/-) were confirmed by genotyping PCR of tail 
DNA from mice at 2-3 weeks of age. (Figure 3.2 B). Southern blot analysis performed by 
Taconic Artemis detecting the correct homologous recombination at 5’side and 
cointegration of proximal loxP sites in the ES clones (Figure 3.2 C). We also observed 
almost no presence of CLPP transcripts thereby confirming Clpp homozygous knockout 
mice (Figure 3.2 D; from Dr. Alexandra Kukat).  
 
Figure 3.2 Confirmation of disruption of Clpp in mice 
(A) Comparison of body sizes of one wild type (+/+) and one homozygous knockout (-/-) CLPP 
animals (Males). (B) Genotyping PCR indicating one heterozygous (+/-), one wild-type (+/+), 
and one homozygous knockout (-/-) CLPP animals. Grey arrow illustrating DNA fragments 
corresponding to the wild type (WT–199 bp), and black arrow indicates knockout (KO–273 bp) 
CLPP loci. (C) Southern Blot analysis of genomic DNA digested with BspHI in control (W) and 
Targeted (targ) ES cells. Black and grey arrow pinpoints (+/+) 14.7kb and targeted (Targ) 12.8kb 
respectively. (D) qPCR analysis of CLPP RNA levels in heart of control (+/+) and Clpp knockout 
(-/-) mice (n=4). Error bar represents ± S.E.M. Asterisks denotes statistical significance 
(Student’s t-test, * p<0.05, ** p<0.01, *** p<0.001). (E) Western blot analysis detecting CLPP 
protein levels in Heart (He), Quadriceps (Quad), Liver (Li), Kidney (Ki), Lung (Lu), Brain (Br) 
of control (+/+) and Clpp knockout (-/-) mice. * indicates cross-reacting band. 
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Western blot analysis also confirmed complete loss of CLPP in heart (He), quadriceps 
(Quad), liver (Li), kidney (Ki), lung (Lu), brain (Br), spleen (Sp) and pancreas (Pa) at 12 
weeks (Figure 3.2 E).  
We observed that Clpp knockouts were not born according to Mendelian proportion 
(Figure 3.3 A). Only 15% of the Clpp knockouts and 43% of heterozygous mice were 
born instead of 25% and 50% respectively. The Clpp-/- homozygous knockout mice were 
smaller than littermates (wild type +/+ as Control) (Figure 3.2 A). However question still 
remains open if the knockout mice were born smaller or not since we observed the 
difference at the time of weaning.  
 
 
Figure 3.3 Phenotypic characterization of CLPP deficiency mouse 
(A) Tabular representation of Mendelian statistics of newborn littermates of control (+/+) and 
Clpp knockout (-/-) mice. (B) Ratio of organ to body weight in mice at 11-15 weeks of age (n=6-
7). Error bar represents ± S.E.M. Asterisks denotes level of statistical significance (Student’s t-
test, *p<0.05, ** p<0.01, *** p<0.001). (C) Graphical representation of change in body weight 
over time in control (+/+) and Clpp knockout (-/-) mice, Females. (D) Graphical representation of 
change in body weight over time in control (+/+) and Clpp knockout (-/-) mice, Males. 
 
We calculated different organ to whole body weight ratio at 11-15 weeks of age and 
found little difference for most organs in Clpp knockout mice. We did observe a higher 
brain weight to body weight ratio in the Clpp knockouts (Figure 3.3 B).  This is likely to 
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be a consequence of little change on brain weight during development and smaller body 
size. We also measured the body weight of control (+/+) and Clpp knockout (-/-) mice for 
both females and males from 4-36 weeks of age and found a significant difference in 
weight (Figure 3.3 C&D). These data suggest that Clpp knockouts are born not following 
Mendelian proportion, smaller and weigh less than their littermates and implying that 
CLPP might play an important role in the developmental stages of the organism. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 59 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Part 1: Role of CLPP in mammalian metabolism  
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3.2. Clpp knockout mice have reduced body fat content, enhanced energy 
expenditure and less ambulatory activity. 
We observed a significant reduction of body weight in Clpp knockout (-/-) animals 
(Figure 3.3 C-D); this compelled us to further analyze the role of CLPP on whole-body 
physiology and metabolism. This part of the work has been done with the help of Dr. 
Alexandra Kukat. Nuclear magnetic resonance analysis of the body composition of the 
animals revealed a prominent decrease in body fat content of Clpp knockout mice (-/-) 
(Figure 3.4 A). We also performed micro computed tomography (microCT) analysis that 
showed a significant decrease in the fat ratio (ratio of average fat to total volume) (Figure 
3.4 B). The observed reduction in body weight might be due to the reduced fat content.  
 
Figure 3.4 Decreased fat mass in Clpp knockout (-/-) mice. 
(A) Average total body fat content measured by NMR in 32-35 weeks old of control (+/+) and 
Clpp knockout (-/-) mice (n= 7 for females; n= 9-11 for males). (B) Fat ratio measured by micro 
computed tomography (microCT) in 32-35 weeks old of control (+/+) and Clpp knockout (-/-) 
mice (n= 7 for females; n= 3 for males). Error bar represents ± S.E.M. Asterisks denotes 
statistical significance (Student’s t-test, * p<0.05, ** p<0.01, *** p<0.001).  
 
To further elucidate the reason behind reduced body fat in Clpp knockout mice (-/-), we 
performed indirect calorimetry on mice fed with normal chow diet. We didn’t find any 
major difference in the food intake between Clpp knockout mice (-/-) and controls (+/+) 
(Figure 3.5 A-B).  We also detected an increase in energy expenditure in Clpp knockout 
females (-/-) as compared to controls (+/+) (Figure 3.5 C).  However we found no major 
difference in energy expenditure in Clpp knockout males (-/-) as compared to controls 
(+/+) (Figure 3.5 D). It remains to be determined if the observed changes reflect gender 
specific differences or are result of low number of animals used in the current 
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experiments. Thus, the enhanced energy expenditure is likely to be a cause for reduced 
body at content in Clpp knockout mice.  
 
 
Figure 3.5 Increased energy expenditure in Clpp knockout (-/-) mice. 
(A-B) Average food intake per day per body weight and per lean mass of control (+/+) and Clpp 
knockout (-/-) females and males respectively, 32-35 weeks old (n= 6-7 for females; n= 4-5 for 
males). (C-D) Energy expenditure normalized to body weight and lean mass for control (+/+) and 
Clpp knockout (-/-) females and males respectively, 32-35 weeks old (n= 7 for females; n= 6-8 
for males). Error bar represents ± S.E.M. Asterisks denotes statistical significance (Student’s t-
test, * p<0.05, ** p<0.01, *** p<0.001).  
 
To investigate the source of energy expenditure we analyzed locomotor activity in these 
Clpp knockout animals (-/-) and found a decrease in activity especially during night for 
both females and males as compared to controls (+/+) (Figure 3.6 A). We also measured 
the rectal body temperature hypothesizing that the energy spend might be dissipated as 
heat. We found no difference in rectal body temperature in Clpp knockout mice (-/-) as 
compared to controls (+/+) (Figure 3.6 B). However the question still remains regarding 
the source of energy expenditure. Hence we need to perform further analysis in 
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measuring the adsorption rate and accessing the calorie content of feaces and urine. In 
addition, it might also be possible that Clpp knockout mice (-/-) are spending more 
energy to maintain optimum body temperature similar to controls (+/+).  
 
 
Figure 3.6 Less activity in Clpp knockout (-/-) mice. 
(A) Average ambulatory activity counts per 30 minutes of control (+/+) and Clpp knockout (-/-) 
females and males respectively, 32-35 weeks old (n= 7 for females; n= 6-8 for males). (B) 
Average rectal body temperature at time point 0 and 30 minutes of control (+/+) and Clpp 
knockout (-/-) females and males respectively, 32-35 weeks old (n= 7 for females; n= 6-8 for 
males). Error bar represents ± S.E.M. Asterisks denotes statistical significance (Student’s t-test, * 
p<0.05, ** p<0.01, *** p<0.001).  
 
 
3.3. Clpp knockout mice have an increase in respiratory quotient (RQ) 
during night, improved glucose tolerance and higher insulin 
sensitivity. 
Indirect calorimetry also provided respiratory quotient (RQ), which is determined as a 
ratio of CO2 eliminated/O2 consumed. RQ values for Clpp knockout (-/-) animals were around 
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0.8 during day and above 1 during night indicating a shift towards fat metabolism and 
carbohydrate metabolism respectively (Figure 3.7 A-B).  
 
Figure 3.7 Increase in respiratory quotient (RQ) in Clpp knockout (-/-) mice. 
 (A-B) Respiratory quotient (RQ) (determined by the ratio of CO2 eliminated/O2 consumed) of control 
(+/+) and Clpp knockout (-/-) females and males respectively (during day and night), 32-35 
weeks old (n= 7 for females; n= 6-8 for males). Error bar represents ± S.E.M. Asterisks denotes 
statistical significance (Student’s t-test, * p<0.05, ** p<0.01, *** p<0.001). 
 
Next we wanted to understand if CLPP deficiency affects glucose homeostasis in addition 
to changes in body weight. We measured glucose concentrations under starved (fasting) 
and random fed (non fasting) conditions. We observed no change in glucose levels 
between Clpp knockout (-/-) and control (+/+) animals under random fed (non fasting) 
conditions (Figure 3.8 A-B). However, we found a significant decrease in glucose 
concentration between Clpp knockout (-/-) and control (+/+) animals under starved 
(fasting) conditions (Figure 3.8 A-B).  
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Figure 3.8 Increase in respiratory quotient (RQ), improved glucose tolerance and 
enhanced insulin sensitivity in Clpp knockout (-/-) mice. 
(A-B) Blood glucose and lactate concentrations in starved and random fed conditions of control 
(+/+) and Clpp knockout (-/-) females and males respectively (n= 7 for females; n= 6-8 for 
males). (C-D) Intraperitoneal glucose tolerance test and intraperitoneal insulin tolerance test 
performed in 32-35 weeks old of control (+/+) and Clpp knockout (-/-) females and males 
respectively (n= 7 for females; n= 6-8 for males). Error bar represents ± S.E.M. Asterisks denotes 
statistical significance (Student’s t-test, * p<0.05, ** p<0.01, *** p<0.001). 
 
In addition, glucose tolerance test performed in Clpp knockout (-/-) females revealed no 
major change in glucose tolerance as compared to control (+/+), but showed a delayed 
response in insulin secretion and faster rate of glucose uptake (Figure 3.8 C). We 
observed an enhanced/improved glucose tolerance for Clpp knockout (-/-) males (Figure 
3.8 D). Moreover, insulin tolerance test revealed higher insulin sensitivity in Clpp 
knockout (-/-) animals with respect to control (+/+) (Figure 3.8 C-D).  
 
 
3.4. Clpp knockout mice age 12-15 weeks have reduced body fat content, 
enhanced energy expenditure and less ambulatory activity.  
We performed similar analysis for younger mice age 12-15 weeks and obtained results 
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consistent with the previous ones in older mice (32-35 weeks). We found a significant 
decrease in body fat content of Clpp knockout (-/-) animals as compared to controls (+/+) 
(Figure 3.9 A).  
 
Figure 3.9 Decreased fat mass, increased energy expenditure in Clpp knockout (-/-) mice. 
(A) Average total body fat content measured by NMR in 12-15 weeks old of control (+/+) and 
Clpp knockout (-/-) mice (n= 20 for females; n= 7-12 for males). (B) Average food intake per day 
of control (+/+) and Clpp knockout (-/-) females and males respectively, 12-15 weeks old (n= 3-6 
for females; n= 4-6 for males). (C-D) Energy expenditure normalized to body weight and lean 
mass for control (+/+) and Clpp knockout (-/-) females and males respectively, 12-15 weeks old 
(n= 3-6 for females; n= 4-6 for males) Error bar represents ± S.E.M. Asterisks denotes statistical 
significance (Student’s t-test, * p<0.05, ** p<0.01, *** p<0.001). 
 
After performing indirect calorimetry on a normal chow diet we did not find any major 
difference in food intake between Clpp knockout males (-/-) and controls (+/+), but on 
the other hand found an increase in food intake for knockout females (-/-) (Figure 3.9 B). 
This discrepancy might be gender specific at earlier age or might be due to the fact that 
we could only use 3 controls for females as compared to 6 controls for males at this age. 
Also, we have performed the data analysis based on absolute values and not adjusted to 
body weight like before. In accordance to our previous result we also found an increase in 
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energy expenditure adjusted to body weight in Clpp knockout mice as compared to 
controls during night (Figure 3.9 C-D).  
Analysis of locomotor activity correlated with our previous results. We found a decrease 
in activity especially during night for Clpp knockout females (Figure 3.10 A). On the 
contrary we observed an increase in activity for knockout males during night (Figure 3.10 
B). This increase in activity might likely explain the enhanced energy expenditure in 
Clpp knockout males (-/-), however we need to repeat the experiment since we have 
undergone the analysis at this age with much lesser number of animals. RQ values 
obtained from indirect calorimetry for Clpp knockout (-/-) animals were around 0.8 
during day and above 1 during night indicating a shift towards fat metabolism and 
carbohydrate metabolism respectively (Figure 3.10 C-D). 
 
Figure 3.10 Less activity in Clpp knockout (-/-) mice. 
(A-B) Average ambulatory activity counts per 30 minutes of control (+/+) and Clpp knockout (-/-
) females and males respectively, 12-15 weeks old (n= 3-6 for females; n= 4-6 for males). (C-D) 
Respiratory quotient (RQ) of control (+/+) and Clpp knockout (-/-) females and males 
respectively (during day and night), 12-15 weeks old (n= 3-6 for females; n= 4-6 for males). 
Error bar represents ± S.E.M. Asterisks denotes statistical significance (Student’s t-test, * p<0.05, 
** p<0.01, *** p<0.001).  
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These are some preliminary interesting observations obtained during the course of on- 
going work on elucidating the role of CLPP at molecular level. Hence we need to 
perform more analysis to understand the role of CLPP in regulating metabolism in 
mammals. The initial studies should include measurement of insulin concentrations, 
circulating free fatty acids, triglycerides, cholesterol, glucose uptake, measuring mass of 
muscle, glycogen content in muscle, activity in brown adipose tissue (BAT) and feeding 
these animals on high fat diet.  
 
 
 68 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Part 2: Role of CLPP in regulating ribosomal biogenesis in mammals 
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3.5. Characterization of mitochondrial proteome revealed oxidative 
phosphorylation (OXPHOS)-respiratory chain, energy metabolism, 
mitochondrial transcription and translation processes to be primarily 
affected in Clpp knockout mice. 
Since CLPP is a mitochondrial matrix protease suggested to play a primary role in quality 
control, thereby maintaining homeostasis in the organelle, we initially wanted to observe 
the global profile changes in relation to protein abundance in the absence of CLPP. This 
analysis also provided us with a global impression of the processes affected and the 
candidates playing roles in those affected process. Thereby, we purified mitochondria 
from heart of Clpp knockout (-/-) and control (+/+) mice using sucrose gradient and 
subjected them to a liquid chromatographic-electrospray ionization-tandem mass 
spectrometric (LC-ESI-MS/MS) analysis. LC-ESI-MS/MS based label free quantitative 
proteomics was carried out in our CECAD proteomic facility. Out of all proteins 
identified 527 were eligible for quantification and have been plotted (Figure 3.11A). 
Value of log2 {ratio of Clpp knockout (-/-) vs control (+/+)} above zero represents 
upregulation of the proteins and below zero represents down regulation of the proteins. 
An increasing value of –Log {p value Clpp knockout (-/-) vs control (+/+)} along X-axis 
indicates higher significance in the change of expression.  We found a number of key 
biochemical and molecular processes along with metabolic processes to be affected in 
absence of CLPP. Out of them, transcription and translation, mitochondrial respiration 
and oxidative phosphorylation (OXPHOS) and metabolism were the key affected 
processes. Proteins that showed higher difference in abundance/expression in the above 
mentioned affected processes were plotted accordingly (Figure 3.11 B-D).  
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Figure 3.11 Quantitative mitochondrial proteome profiling using LC-ESI-MS/MS 
(A) A liquid chromatographic-electrospray ionization-tandem mass spectrometric (LC-ESI-
MS/MS 4 hr. gradient) analysis for the quantification of proteins from purified heart mitochondria 
of control (+/+) and Clpp knockout (-/-) mice (n=4). (B-D) Representation of the differentially 
expressed proteins involved in the affected biochemical and molecular pathways in absence of 
CLPP. 
 
 
3.6. CLPP deficiency leads to a specific decrease in Complex I activity, 
followed by a decrease in Complex IV activity later in life. 
Label free quantification analysis of mitochondrial proteome showed that mostly 
respiratory chain & oxidative phosphorylation (OXPHOS), mitochondrial translation and 
metabolic processes were affected. Hence, we wanted to first investigate the biochemical 
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effects of CLPP deficiency in heart by measuring the levels of mitochondrial respiratory 
chain (MRC) activities (Figure 3.12 A) in collaboration with Dr. Rolf Wibom 
(Karolinska Institute, Sweden). We observed an isolated Complex I deficiency at 15 
weeks, which was followed by combined decrease in Complex I and Complex IV activity 
later in life (35 weeks). Complex II, which is encoded by nuclear DNA, remained 
unaffected. This indicates that mitochondrial gene expression is specifically affected in 
Clpp deficient mice. Decrease in Complex I (Figure 3.12 B) and Complex IV activity 
(Figure 3.12 C) was also reflected in in-gel activity in heart and achieved similar results 
for Complex I and Complex IV in skeletal muscle (Skm) (Figure 3.12 B-C).  
 
Figure 3.12 Loss of CLPP causes mitochondrial dysfunction in Clpp knockout mice 
(A) Relative MRC activities in isolated heart mitochondria of control (+/+) and Clpp knockout  
(-/-) mice (n=4) of 15 weeks and 35 weeks of age. (B-C) In gel activity of Complex I and 
Complex IV in heart and skeletal muscle (SkM) after running BN-PAGE. (D) Measurement of 
oxygen consumption of isolated heart mitochondria of control (+/+) and Clpp knockout (-/-) mice 
(n=7). Error bar represents ± S.E.M. Asterisks denotes statistical significance (Student’s t-test, * 
p<0.05, ** p<0.01, *** p<0.001).  
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Furthermore, we measured oxygen consumption in isolated heart mitochondria when 
supplied with substrates of Complex I (pyruvate-glutamate-malate) and ADP, OXPHOS 
state CI; followed by addition of substrates of Complex II (succinate), OXPHOS state 
CI+CII. LEAK respiration (state L) is the LEAK oxygen flux, compensating for proton 
leak. LEAK respiration determines the mitochondrial respiration in the LEAK state after 
adding oligomycin that is an inhibitor of ATP synthase (inhibits state 3- phosphorylating 
respiration). The capacity of the electron transfer system (ETS) was evaluated by 
complete uncoupling by addition of uncoupler carbonyl cyanide p-[rifluoromethoxyl]-
phenyl-hydrozone (FCCP) thereby stimulating maximum flux. Finally addition of 
rotenone that inhibits Complex I show the contribution of Complex II to the maximal 
ETS capacity. We obtained a reduction in oxygen consumption rate for both OXPHOS 
state CI and OXPHOS state CI+CII in Clpp knockout mice (Figure 3.12 D). We also 
found a decrease in LEAK respiration and lower capacity of the ETS in Clpp knockout 
mice supporting the results of the complex activities. 
We next proceeded to assess the levels of assembled respiratory chain complexes by 
using Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE) and detected lower 
levels of Complex I and mild reduction of Complex IV in Clpp knockout heart and 
skeletal muscle mitochondria of 15-19 weeks age (Figure 3.13 A). In addition to the fully 
assembled complexes, we also detected a smaller band (marked by arrow, Figure 3.13 A) 
that likely corresponds to F1 of Complex V in Clpp knockout heart. Similar observations 
have been previously reported in other knockout mouse models with impaired mtDNA 
expression 34,39,41,111,113. We also procured lower levels of Complex I and Complex IV for 
assembled respiratory supercomplexes (Figure 3.13 B). Since Complex I seemed to be 
primarily affected we then examined the assembly status for Complex I by performing 
two-dimensional blue native/ SDS gel electrophoresis in collaboration with 
Prof. Leo Nijtmans (NCLMS, Netherlands) (Figure 3.13 C).  After separating the intact 
OXPHOS complexes by first dimension blue native PAGE, the second dimension 
denaturing electrophoresis resolves the individual subunits of respective complexes. The 
distribution of these subunits thereby determines possible subcomplexes. Western blot 
analysis using Complex I subunit specific antibodies NDUFS3 and NDUFA9 showed no 
accumulation of subcomplexes of either partially assembled or breakdown products 
thereby indicating no assembly defect for Complex I. This indicates that Complex I 
deficiency likely stems from the increased turnover of Complex I. 
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Figure 3.13 Lower levels of Complex I and Complex IV in Clpp knockout mice. 
(A) BN Page analysis of the assembled respiratory chain complexes in heart and SkM 
mitochondria of control (+/+) and Clpp knockout (-/-) mice of 12-15 weeks respectively. (B) BN 
Page analysis of the assembled respiratory chain super complexes in heart mitochondria of 
control (+/+) and Clpp knockout (-/-) mice of 12-15 weeks respectively. Immunoblotting was 
performed to detect nuclear-encoded subunits of complex I (NDUFA9), complex II (SDHA), 
complex III (UQCRC2), complex IV (COXI) and complex V (ATP5A1). (C) 2D BN Page 
analysis in heart mitochondria of control (+/+) and Clpp knockout (-/-) mice. Immunoblotting 
was done to detect NDUFA9 and NDUFS3 subunits of complex I.  
 
 
3.7. Loss of CLPP leads to increase in transcription followed by increased 
steady state levels of mtDNA transcripts  
The respiratory chain dysfunction driven by loss of CLPP prompted us to inspect mtDNA 
levels and mtDNA expression. Southern blot analysis showed mild increase in levels of 
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mtDNA in the heart of Clpp knockout (-/-) mice as compared to control (+/+) (Figure 
3.14 A). This finding of ours disputes with previous study 114 where it has been reported a 
significant increase of mtDNA levels in heart of Clpp knockout (-/-) mice as compared to 
control (+/+). This difference may be due to the methods used in both studies. 
Quantitative real time PCR was used in the previous study whereas we performed 
Southern blot.  
 
Figure 3.14 Steady state levels of mtDNA in heart of Clpp knockout mice 
(A) Southern blot analysis of mtDNA levels in heart of control (+/+) and Clpp knockout (-/-) 
mice. Quantification of mtDNA levels (n=4) of control (+/+) and Clpp knockout (-/-) mice of 15 
weeks of age. Error bar represents ± S.E.M. Asterisks denotes level of statistical significance 
(Student’s t-test, *p<0.05, ** p<0.01, *** p<0.001). 
 
We next examined the steady state levels of mRNAs, tRNAs and rRNAs generated from 
the heavy strand promoter (HSP) and light stand promoter (LSP) of mtDNA in the heart 
of Clpp knockout (-/-) mice (Figure 3.15 A-B). We found a significant increase in 
mRNAs and tRNAs transcribed from HSP & LSP of mtDNA in heart of Clpp knockout (-
/-) mice. The levels of 16S rRNA were mildly decreased, whereas we found elevated 
levels of RNA19; that circumscribe 16S rRNA and ND1 (Figure 3.23 A). This might 
imply towards impairment in processing of transcripts (Figure 3.23 A), here more 
specifically the processing of RNA19.   
 75 
 
Figure 3.15 Steady state levels of mitochondrial transcripts in heart of Clpp knockout mice 
(A) Northern blot analysis of mitochondrial rRNA, mRNA and tRNA of control (+/+) and Clpp 
knockout (-/-) mice. 18S rRNA is used as loading control. (B) Quantification of mitochondrial 
rRNA, mRNA and tRNA levels in heart which is presented as percentage of control (+/+) (n=4). 
Error bar represents ± S.E.M. Asterisks denotes level of statistical significance (Student’s t-test, 
*p<0.05, ** p<0.01, *** p<0.001).  
 
In addition, increase in steady state levels of LRPPRC that is known to regulate 
mitochondrial mRNA stability 111 corresponds to the increase in steady state levels of 
most mRNAs (Figure 3.16 A). Later we also performed in organello transcription (with 
Dr. Alexandra Kukat) that resulted in an increase of de novo transcription of mtDNA in 
heart and SkM of Clpp knockout (-/-) mitochondria (Figure 3.16 B). This upregulation of 
transcription is likely to be a secondary response or a compensatory mechanism to 
respiratory chain deficiency. Interestingly we found a decrease in de novo transcription of 
mtDNA in liver (Figure 3.16 B). 
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Figure 3.16 In organello transcription in heart of Clpp knockout mice 
(A) Western blot analysis of steady state levels of LRPPRC protein that regulates mitochondrial 
mRNA stability. (B) In organello transcription of control (+/+) and Clpp knockout (-/-) heart, 
SkM and liver mitochondria. 
 
 
3.8. Loss of CLPP leads to impaired mitochondrial protein synthesis 
accompanied by increased levels of small ribosomal subunits, thereby 
affecting the stoichiometry of proper functioning ribosomes 
The upregulation of transcription induced by loss of CLPP compelled us to also inspect 
de novo protein synthesis in isolated mitochondria from heart, SkM and liver of Clpp 
knockout (-/-) mice. We found moderate decrease in mitochondrial translation as depicted 
in 1 hour radioactive S35 labeling (Pulse-Figure 3.17 A) of newly synthesized 
mitochondrial proteins. To analyze the stability of the newly synthesized polypeptides, 3 
hours Chase was performed in the presence of cold methionine. Moderate aberrations in 
mitochondrial translation lead us to analyze the assembly status of mitochondrial 
ribosomes. We analyzed the integrity of mitochondrial ribosomes by gradient 
sedimentation analysis of mitochondrial extracts (Figure 3.18 A). We detected an 
increase in steady state levels of small ribosomal subunits (28S) while large ribosomal 
subunits (39S) and monosomes (55S) appeared to be present in almost normal levels. 
This is in contrast with the previous observation where 16S rRNA levels are decreased. 
This suggests that the stoichiometry of mitochondrial ribosomes might be affected 
leading to dysfunction of monosomes. 
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Figure 3.17 Deregulated protein synthesis in Clpp knockout heart, SkM and liver.  
(A) In organello translation of isolated heart, SkM and liver mitochondria from control (+/+) and 
Clpp knockout (-/-) mice. De novo synthesized mitochondrial encoded proteins were isolated 
after labeling with 35S-methionine for 1 hour (Pulse). Positions of individual mitochondrial 
encoded proteins are indicated. Coomassie blue stained gel is used to indicate equal loading of all 
lanes. 
 
Moreover, we also detected an increase in small ribosomal subunits MRPS15 and 
MRPS35, with mild increase in large ribosomal subunits MRPL37 (Figure 3.18 B). This 
is in agreement with the biogenesis of mitochondrial ribosomes and also supports the 
observation from sedimentation analysis. This increased mitochondrial ribosomal 
biogenesis might be a response to respiratory chain deficiency caused by a possible 
problem in translation in the absence of CLPP. 
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Figure 3.18 Biogenesis of small ribosomal subunits in Clpp knockout heart  
(A) Sedimentation analysis of small (28S), large (39S) ribosomal subunits and assembled (55S) 
ribosome in heart mitochondria from of control (+/+) and Clpp knockout (-/-) heart mitochondria 
by centrifugation through linear 10%–30% sucrose density gradient. The migration of ribosomal 
subunits and assembled (55S) ribosome was detected by immunobloting with MRPS15, 
MRPS35, MRPL12 and MRPL37 specific antibodies. (B) Steady state levels analyzed by 
Western blot of MRPS15, MRPS35 of the small (28S) ribosomal subunit and MRPL37 protein of 
the large (39S) ribosomal subunit from of control (+/+) and Clpp knockout (-/-) heart 
mitochondria. VDAC is used as a loading control. (C) Western blot analysis of mitochondrial 
translation proteins EF-TUmt, EF-G1mt, IF2mt, IF3mt of control (+/+) and Clpp knockout (-/-) heart 
mitochondria. TOM20, VDAC are used as loading controls.  
 
To further address the observed defect of mitochondrial translation, we performed 
Western blot analysis of the mitochondrial translational factors. We observed no change 
in steady state levels of EF-TUmt and increase in steady state levels of EF-G1mt 
(translational factors involved in elongation) (Figure 3.18 C). We didn’t detect any 
change in the levels of initiation factor IF2mt of mitochondrial translation which goes well 
with its primarily role in binding of GTP and then to the small ribosomal subunit (28S) 39.  
We found an increase in steady state levels of IF3mt that is involved in interacting with 
the 55S mitoribosome thereby loosening the interaction of 28S and 39S in the first step of 
initiation of mitochondrial translation. This leads to the release of 39S and formation of 
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28S:IF3mt complex in the second step of initiation 42. All the above results implied to 
impairment in the assembly of small ribosomal subunit that also might affect the function 
of fully assembled ribosomes. 
 
 
3.9. tRNA acetylation is not affected in absence of CLPP in heart  
Impaired mitochondrial translation and accumulation of small ribosomal subunits might 
lead to the possibility of stalled ribosomes, since in bacteria it has been shown that CLPP 
plays a role in rescuing stalled ribosomes115. This led us to the following hypothesis:  
a. Absence of ClpXP protease in the mice might inhibit the proteolysis process in 
mitochondria thereby preventing generation of peptides, which in turn will lead to fewer 
amounts of amino acids. This scarcity of amino acids will result in less amount of 
acylated tRNAs (charging of tRNAs) thereby impeding the mitochondrial translation 
process. 
b. Aberration of mitochondrial translation might also be due to the any premature stalling 
of ribosomes on mRNA that has been cleaved due to the lack of a stop codon. In such 
scenario, recruitment of release factors takes place that cleaves the peptidyl-tRNA 
releasing the nascent polypeptide chain. CLPP being one of the primary mitochondrial 
matrix protease involved in the quality control process might be responsible for 
degradation of this nascent polypeptide chains into small peptides. But in absence of 
CLPP, these polypeptides might not be degraded into peptides which will result in less 
amount of amino acids thereby affecting the charging of tRNAs necessary for 
mitochondrial translation. 
c. Stalling of ribosomes in Clpp knockout (-/-) heart might also inhibit the ribosomal 
subunit dissociation and preventing the release of deacylated tRNA and mRNA. This will 
also result in lesser amount of uncharged (deacylated) tRNAs.  
Therefore we estimated the levels of aminoacylated tRNAs by separating the charged and 
uncharged forms of tRNA under acidic conditions (Figure 3.19 A). We found an increase 
amount of both charged (acylated) and uncharged (deacylated) tRNAs in Clpp knockout 
(-/-) heart and liver. Elevated levels of charged tRNAs might be due to higher steady state 
levels of tRNAs (Figure 3.15 A-B). This observation also implies that there is no problem 
regarding the availability of the amino acids hence ruling out our hypothesis in a&b. 
Moreover, increased amount of uncharged tRNAs also rules out the hypothesis in c since 
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deacylated tRNA are getting released at the end of elongation phase and available for 
successive rounds of translation. This indicates that the translation process till elongation 
phase is likely proceeding without major inhibition.  
 
Figure 3.19 Increase in levels of charged and uncharged forms of tRNAs in absence of 
CLPP in heart and liver.  
(A) Aminoacylation assay for mitochondrial tRNALeu, tRNAVal, tRNAPhe and tRNALys in heart 
and liver of control (+/+) and Clpp knockout (-/-) mice. Positions of charged (AA-tRNAAA) and 
uncharged (tRNAAA) tRNAs are indicated. Deacylated (DA) or uncharged (tRNAAA) tRNAs from 
control (+/+) and Clpp knockout (-/-) mice are used as Control for the experiment.  
 
 
3.10. Identification of CLPP candidates with a possible role in 
mitochondrial translation 
To identify the substrates of CLPP and its possible role in mitochondrial translation we 
developed a catalytically inactive version of CLPP by mutating Serine 149 to Alanine.  
This mutational disruption of active site inactivated the catalytic activity of CLPP, 
thereby leading to trapping of the substrates inside the channel of CLPP barrel when 
produced by its partner CLPX. We did the trapping of substrates of CLPP in mouse 
embryonic fibroblasts cells (MEFs). For trapping of CLPP substrates the above 
mentioned immortalized cells were used. Trapping of CLPP and identification of 
substrates and interactors has been performed by Dr. Karolina Szczepanowska. Transient 
expression (48 hours) was obtained after transfection of Clpp knockout MEFs with the 
constructs driven under CMV promoter as depicted in (Figure 3.20 A). Mitochondria was 
isolated followed by co immunoprecipitation with Anti-FLAG antibody and subsequently 
send for Mass Spectrometry analysis. Of the total number of proteins identified 286 
(approximately 50%) were mitochondrial proteins, 134 proteins were shared between WT 
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(CLPP+/+), KO (CLPP-/-) and TRAP (CLPPTRAP). From this analysis, the most promising 
candidates in relation to post-transcriptional and translation processes are represented in 
the table (Figure 3.20 B) which are ERAL1, P32, EF-G1mt, PNPT1 and MRPP1.  
• ERAL1 has been previously shown to be associated with small mitoribosomal 
proteins including 12S rRNA, act as a chaperone protecting 12S rRNA, involved 
in assembly of the 28S small ribosomal subunits of and formation of functional 
small ribosomal subunits 116,117.  
• P32 has been shown to be multifunctional, possessing important role in 
mitochondrial translation, apopotosis and formation of functional ribosomes 118,119   
• EF-G1mt is the elongation factor and is known to be involved in mitochondrial 
translation 50.  
• PNPT1 has been shown to be a RNA binding protein and engaged in numerous 
RNA metabolic processes. PNPT1 is involved in mRNA processing and 
polyadenylation and hydrolyzes single-stranded polyribonucleotides in the 3'-5' 
direction. It also plays a role in RNA import into matrix 120–123.  
• MRPP1 is ribonuclease P Protein 1 has been shown to be involved in 
5’processing of mitochondrial tRNAs, is essential for RNA modification and 
translation 124. 
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Figure 3.20 Selected substrates and partners of CLPP involved in mitochondrial translation 
and RNA processing identified in Clpp knockout (-/-) MEFs. 
(A) Strategy of identification of CLPP substrates and partners in mammalian Clpp knockout (-/-) 
MEFs. (B) Tabular representation of selected substrates and partners of CLPP.  
 
In order to determine if the above mentioned promising candidates are substrates of 
CLPP, they need to fulfill the following criteria: 
a. No change in their expression at transcript levels. 
b. They are stabilized in Clpp deficient cells and are increased in their steady state levels. 
c. Direct interaction between the candidates and CLPP. 
d. In vitro degradation of the candidates by CLPP. 
To validate ERAL1, EF-G1mt, MRPP1 and CLPX as the substrates of CLPP, we 
performed real time PCR analysis and found non-significant changes of the transcripts in 
heart of Clpp knockout (-/-) mice. (Figure 3.21 A, from Dr. Alexandra Kukat) thereby 
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fulfilling the first criteria. Moreover, we detected an increase in the steady state levels of 
ERAL1, EF-G1mt, MRPP1, CLPX, PNPT1 whereas no change in levels of P32 (Figure 
3.21 B) fulfilling one of the requirements of being substrates. We got similar results from 
label free analysis of purified heart mitochondria from control (+/+) and Clpp knockout (-
/-) mice supporting that the elevated levels of the substrates is due to its accumulation in 
the mitochondria in absence of CLPP and not due to upregulation of transcription.   
 
Figure 3.21 Steady state levels of potential candidates at RNA and protein levels 
(A) Relative expression levels of ERAL1, P32, CLPX, EF-G1mt, PNPT1 and MRPP1 from 
control (+/+) and Clpp knockout (-/-) heart (n=4). Error bar represents ± S.E.M. Asterisks denotes 
level of statistical significance (Student’s t-test, *p<0.05, ** p<0.01, *** p<0.001).  (B) Western 
blot analysis of promising candidates ERAL1, MRPP1, PNPT1, CLPX and P32 of control (+/+) 
and Clpp knockout (-/-) heart mitochondria. VDAC and TOM20 are used as loading controls.  
 
After performing cyclohexamide (CHX) chase of cytoplasmic protein synthesis, the 
stability (turnover, half-life) of ERAL1, EF-G1mt, MRPP1 were enhanced, supporting 
strongly that ERAL1, EF-G1mt and MRPP1 are substrates of CLPP (Figure 3.22 A, from 
Dr. Karolina Szczepanowska). We observed no change in the stability of P32 and PNPT1 
thereby leaving a possibility of being interactors. It has been shown previously that CLPP 
interacts with CLPX 125. From the co-immunoprecipitation analysis of CLPP (FLAG) and 
CLPX with P32 (Figure 3.22 B, from Dr. Karolina Szczepanowska), we observed that 
P32 interacts with CLPP. Currently we are performing experiments showing interaction 
between other candidates and CLPP. 
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Figure 3.22 Stabilization of potential candidates  
(A) Determination of the stability (turnover, half-life) of selected candidates using the 
cycloheximide (CHX) chase of cytoplasmic protein synthesis. (B) Co-immunoprecipitation of 
CLPP (FLAG) and CLPX with P32 in mitochondria from MEFs expressing CLPP-FLAG2. 
Western blot analysis of loading, flow through, eluate fractions shows that P32 antibody 
specifically immunoprecipitate CLPP (detected with anti-Flag antibody) and CLPX. 
 
 
3.11. A possible role of CLPP in processing of RNA transcripts 
Interestingly we found a significant accumulation of precursors of mRNAs and tRNAs in 
absence of CLPP indicating towards a problem in the processing of transcripts involving 
MRPP1 which has been shown to be a substrate (Figure 3.23 A). Previously 
accumulation of precursor for mRNA transcripts has been reported in knockout mouse 
models of MTERF3 known as a negative regulator of mtDNA transcription initiation 39, 
MTERF4 that has been shown to control mitochondrial ribosomal biogenesis and 
translation 41. In addition, loss of function of GRSF1, an RNA binding protein interacting 
with RNase P lead to accumulation of tRNA precursors due to aberrant mitochondrial 
RNA processing 126. However to address the question if CLPP has any specific role in 
maturation of the transcripts in general involving MRPP1 and PNPT1 we are currently 
performing further experiments. 
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Figure 3.23 Accumulation of precursors of mRNAs and tRNAs in absence of CLPP 
(A) Northern blot analysis of mitochondrial mRNA and accumulation of precursors (indicated by 
arrows) of control (+/+) and Clpp knockout (-/-) mice. Quantification of mitochondrial mRNA 
and tRNA precursor levels in heart, which is presented as percentage of control (+/+) (n=4). Error 
bar represents ± S.E.M. Asterisks denotes level of statistical significance (Student’s t-test, 
*p<0.05, ** p<0.01, *** p<0.001). 
 
 
3.12. ERAL1 and P32 interacts with the mitoribosomes  
To investigate the migration of the substrates and interactors of CLPP with small, large 
subunits and monosomes, we performed gradient sedimentation analysis of mitochondrial 
extracts from heart of Clpp knockout (-/-) mice. Co migration of MRPS35 and MRPL12 
has been used as markers for 28S (small) and 39S (large) ribosomal subunits respectively 
(Figure 3.24 A). Co migration of MRPS35 and MRPL12 were used as markers for fully 
assembled monosomes (55S). We observed an abnormal migration pattern of all the 
candidates in Clpp knockout (-/-) where it is present in much higher abundance through 
out the small, large and monosomes in differential amount. Migration of ERAL1 implied 
mostly with the small (28S) ribosomal subunit and P32 largely with large (39S) 
ribosomal subunit along with monosomes (55S). CLPX and EFG1 showed similar 
migration pattern predominantly with small (28S) and large (39S) ribosomal subunits 
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(Figure 3.24 B). However we also observe migration of CLPX and EF-G1mt with 
monosome (55S) but in lower amount. This might be due to sample loss during the 
processing of experiment.  
 
Figure 3.24 Substrates and interactors of CLPP are associated with mitochondrial 
ribosomes. 
(A) Sedimentation analysis of ERAL1, P32 along with small (28S), large (39S) ribosomal 
subunits and assembled (55S) ribosome in heart mitochondria from of control (+/+) and Clpp 
knockout (-/-) heart mitochondria by centrifugation through linear 10%–30% sucrose density 
gradient. The migration of the potential candidates was detected by immunoblotting with 
MRPS35, MRPL12 ERAL1 and P32 antibodies. Furthermore in a parallel experiment 
Mitochondria were lysed and then treated with RNase A for 30 min at 37C to disintegrate 
mitochondrial ribosomes and analyze the association of the potential candidates with 
mitochondrial ribosomes (B) Similar to (A) the migration of migration of the potential candidates 
was detected by immunoblotting with CLPX and EFG1 antibodies. 
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3.13. Clpp deficiency leads to impairment of 12S rRNA assembly into 
monosomes leading to lower loading of mitochondrial mRNAs.  
ERAL1 has been shown to be a substrate of CLPP and found to be mostly bound to the 
small (28S) ribosomal subunit (Figure 3.24 A). This implied primarily towards a problem 
with the assembly of small (28S) ribosomal subunit since ERAL1 is known as a chaperon 
for 12rRNA. This assembly defect in turn might perturb the stoichiometry of fully 
assembled monosome (55S) thereby affecting its proper function. To validate this we 
next performed similarly sucrose gradient sedimentation analyses of mitochondrial 
extracts from heart of Clpp knockout (-/-) mice (with Dr. Alexandra Kukat). MRPS35 
and MRPL12 have been used as markers for migration of small (28S), large (39S) 
ribosomal subunits and monosomes (55S) (Figure 3.25 A). We then used TaqMan 
specific probes to measure levels of 12S rRNA and 16S rRNA in the different fractions 
and found that 12S rRNA co migrated with MRPS35 protein and 16S rRNA with 
MRPL12 in Control (+/+) mitochondria (Figure 3.25 B). We observed an abnormal 
distribution of 12S rRNA to a greater extent in small subunit fraction (28S) and to a much 
lesser extent in monosome fraction (55S). Later we analyzed migration of three different 
mRNAs and observed two different prominent pools of these mRNAs in Control (+/+) 
mitochondria. The first pool was towards the top of the gradient pertaining to low 
molecular weight region (fractions 2-3) followed by the second pool migrated towards 
the bottom of the gradient resembling to high molecular weight region with the 
assembled monosomes (55S) (fractions 11-12). The abundance of mRNAs in these two 
pools differed in Clpp knockout (-/-) mitochondria, with much higher levels in the first 
pool (fractions 2-3) than in second pool (fractions 11-12) as compared to Control (+/+). 
This suggested that only a fraction of mRNAs is getting translated in a particular time 
indicating a possible hindrance in translation process. This might be due to highest levels 
of ERAL1 that caused an impairment of 12S rRNA assembly into small subunit finally 
leading to lower loading of mitochondrial mRNAs on monosomes. 
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Figure 3.25 Substrates and interactors of CLPP likely to be involved in the assembly of 12S 
RNA into the small ribosomal subunit thereby affecting the function of monosomes 
(A) Sedimentation analysis of small (28S), large (39S) ribosomal subunits and assembled (55S) 
ribosome from control (+/+) and Clpp knockout (-/-) heart mitochondria by centrifugation 
through linear 10%–30% sucrose density gradient. The migration of the small and large 
ribosomal subunits was detected by immunobloting with MRPS35 and MRPL12 antibodies and 
was used as reference. (B) Sedimentation profiles of mitochondrial transcripts in heart 
mitochondrial of control (+/+) and Clpp knockout (-/-) mice. Individual mitochondrial transcripts 
were detected using TaqMan-specific probes. The abundance of mRNA in each fraction is 
represented as percentage of the sum of the total abundance in all fractions.  
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3.14. Investigation of phenotype in Clpp knockout MEFs revealed lower 
levels of assembled respiratory chain supercomplexes. 
To further elucidate the course of action through which CLPP along with its substrates 
and interactors are regulating the translation process, we are currently performing siRNA 
knockdown of the possible substrates thereby hoping to rescue the defect. Initially, in 
order to search for a phenotype in Clpp knockout (-/-) MEFs resembling the observed 
effect in Clpp knockout (-/-) mice, we focused on the physiological aspect in terms of 
growth rate (population doublings) (Figure 3.26 A, from Dr. Alexandra Kukat). We 
didn’t find any significant changes in the growth rate of control (+/+) and Clpp knockout 
(-/-) MEFs grown both in glucose and galactose supplemented medium. We then carried 
out in cello translation in control (+/+) and Clpp knockout (-/-) MEFs grown on both 
glucose and galactose medium but didn’t see any translational aberration after labeling 
with 35S-methionine for 1 hour (Pulse) (Figure 3.26 B, from Dr. Alexandra Kukat). 
Furthermore, fluorescence microscopy images exhibited no deformation of the 
mitochondrial network in Clpp knockout (-/-) MEFs (Figure 3.26 C, from Dr. Alexandra 
Kukat). Next we performed gradient sedimentation analysis of mitochondrial extracts 
from MEFs grown on glucose and then switching then to galactose for 13 hours shifting 
cellular energy dependency using OXPHOS (Figure 3.26 D). Here we found lower 
amounts of small ribosomal subunits (28S) and large ribosomal subunits (39S). Though 
the migration pattern of ERAL1 and P32 in Clpp knockout (-/-) MEFs was similar to that 
observed in mice, but both of them migrated primarily with small ribosomal subunits 
(28S). We also did the similar sedimentation analysis for MEFs grown in galactose 
medium (Figure 3.26 E). Here we found lower amounts of small ribosomal subunits 
(28S) and no change in large ribosomal subunits (39S) along with monosome (55S). The 
migration pattern of both ERAL1 and P32 was primarily with small ribosomal subunits 
(28S) alike the previous sedimentation analysis. However interestingly, we found a shift 
in the distribution of monosomes in Clpp knockout (-/-) MEFs (fractions 9-11) as 
compared to control (+/+) (fractions 10-12). This implies that the formation of functional 
monosomes (55S) is affected thereby altering the stability. We used TaqMan probes to 
measure levels of 12S rRNA, 16S rRNA in different fractions and surprisingly found that 
12S rRNA didn’t co migrated with MRPS35 protein in Control (+/+) MEFs (Figure 3.26 
E, with Dr. Alexandra Kukat), whereas 16S rRNA did co migrated with MRPL12. In 
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addition, for Clpp knockout (-/-) MEFs, 12S rRNA and 16S rRNA both comigrated with 
MRPS35 and MRPL12 respectively. We also analyzed the migration of three different 
mRNAs and observed a major pool towards the top of the gradient pertaining to low 
molecular weight (fractions 2-4). This suggested that a major fraction of mRNAs is not 
getting translated in a particular time due to unstable monosomes (55S). Nonetheless, we 
need to repeat this experiment since there is discrepancy of the migration of 12S rRNA 
with MRPS35. We have identified lower levels of Complex I for assembled respiratory 
supercomplexes in Clpp knockout (-/-) MEFs grown in galactose (data not shown). 
Currently we are performing siRNA knockdown experiments of the substrates of CLPP 
and observing the rescue at the level of assembled respiratory supercomplexes.  
 
 91 
 
 92 
Figure 3.26 Phenotypic characterization of Clpp knockout MEFs 
(A) Population doublings of control (+/+) and Clpp knockout (-/-) immortalized MEFs over 
passages. (B) In cellular translation of control (+/+) and Clpp knockout (-/-) immortalized MEFs. 
De novo synthesized proteins were isolated after labeling with 35S-methionine for 1 hour (Pulse). 
Positions of individual mitochondrial encoded proteins are indicated. Coomassie blue stained gel 
is used to indicate equal loading of all lanes. (C) Fluorescence microscopy images depicting the 
mitochondrial network of control (+/+) and Clpp knockout (-/-) immortalized MEFs. 
Mitochondrial network is detected by membrane potential dependent MitoTracker Red CMXRos 
red fluorescent dye and nucleus is stained by DAPI blue fluorescent stain. (D) Sedimentation 
analysis of ERAL1, P32 along with small (28S), large (39S) ribosomal subunits and assembled 
(55S) ribosome from control (+/+) and Clpp knockout (-/-) immortalized MEFs grown in glucose 
medium and switched to galactose medium for 13 hours. The migration of the potential 
candidates was detected by immunobloting with MRPS35, MRPL12 ERAL1 and P32 antibodies. 
(E) Similar to (D) the migration of 28S, 39S and 55S from control (+/+) and Clpp knockout (-/-) 
immortalized MEFs grown in galactose medium is depicted for reference. Sedimentation profiles 
of mitochondrial transcripts in control (+/+) and Clpp knockout (-/-) immortalized MEFs grown 
in galactose medium. Individual mitochondrial transcripts were detected using TaqMan-specific 
probes. The abundance of mRNA in each fraction is represented as percentage of the sum of the 
total abundance in all fractions. 
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4. Discussion 
The role of CLPP in various organisms has been studied in recent years; however, the 
biological role of CLPP protease in mammals is poorly understood. In the current study, 
we investigated the role of mitochondrial matrix protease CLPP at physiological and 
molecular levels by assessing the Clpp knockout mouse. Only around 60% of Clpp 
deficient mice are born indicating an important role of CLPP in the developmental stages 
of the organism. It is unclear at which developmental stage of the organism the remaining 
embryos are getting destroyed. This is in agreement with a study performed in 
eubacterium C. crescentus, where it has been shown that ClpXP protease is essential for 
cell-cycle-dependent turnover of CtrA, which is an inhibitor of G1-to-S phase transition. 
Therefore, cells lacking ClpXP are arrested in the G1 phase and blocked the cell division 
process, indicating importance of ClpXP specific degradation of CtrA 100. Although this 
study in bacteria indicated an important role of ClpXP for maintaining normal cell 
division and growth of the organism, we need to perform further analysis to support the 
important role of CLPP in mammalian development. 
We observed specific phenotypes in Clpp knockout mice that pointed out a potential role 
of CLPP in regulating specific candidates involved in various molecular, biochemical and 
metabolic pathways. We noticed some striking phenotypes or features of the Clpp 
knockout mice, (a) they are smaller than their wild type littermates indicating growth 
retardation; (b) they are infertile; (c) diminished activity that can be linked to 
mitochondrial pathology. These features represent classical symptoms and a faithful 
model of human Perrault syndrome that occurs due to missense mutations in Clpp and is 
primarily characterized by sensorineural hearing loss (SNHL), premature ovarian failure 
and short stature 107. Surprisingly, loss of CLPP seems not to affect the longevity, since in 
our hands they live for at least two years, unlike other mouse models lacking genes 
essential for mtDNA expression 34,39,41,111,127. In contrast to our results, another study 
showed that Clpp knockout mice lived for around one year 114. This contradiction in 
results might be due to difference in the total number of animals used for lifespan 
experiments although both studies obtained similar phenotypes for the Clpp knockout 
mice. This discrepancy could also be a result of different technique used to obtain the 
Clpp deficient model. The previous study used gene-trapping method to generate 
 94 
knockout mice whereas we used gene targeting. Gene trapping is a random process and is 
not as efficient or specific as gene targeting since not every successful insertion of 
artificial DNA into a gene will lead to a loss of function. Since gene trapping is a random 
process certain genes may never get hit due to statistics or because the gene is not active 
in ES cells thereby not producing the marker indicating that the gene has been knocked 
out. In addition, various studies have shown biasness of trapping vectors and some 
‘‘cold’’ genomic spots on the chromosomes that remained untrapped143, 144,145. However 
our results are supported by another study in the filamentous fungus P. anserine, where 
deletion of ClpP results in an extension of healthy lifespan under normal growth 
conditions 128. It has been proposed that under normal growth conditions, lack of PaClpP 
might cause a mild but tolerable stress leading to mitochondrial hormesis thereby leading 
to beneficial activation of maintenance and repair pathways that results in this lifespan 
extension 129. Currently we are performing a new study with increased number of animals 
to determine the maximum lifespan in our Clpp deficient mice.  
We have observed that Clpp knockout mice are smaller than their littermates and have a 
significant reduction in body weight. It is unclear if they are born small or it is a gradual 
decrease in body weight with age. In the previously described Clpp deficient mice study, 
it has been reported that the Clpp knockout mice weigh normal until weaning followed by 
reduced weight gain throughout adulthood 114. Our initial studies showed lower body fat 
content, enhanced energy expenditure, less ambulatory activity, increase in respiratory 
quotient (RQ) during night indicating towards a shift to fatty acid metabolism, improved 
glucose tolerance and higher insulin sensitivity in the Clpp knockout animals. At the 
same time label free quantification analysis suggested different metabolic pathways to be 
one of the key affected processes. Similar observations were reported in a previous study 
where mitochondrial transcription factor A (TFAM) in adipose tissue was disrupted 146. 
These mice exhibited altered levels of proteins of electron transport chain, mitochondrial 
dysfunction with decreased complex I activity and increased uncoupling that resulted in 
increasing mitochondrial oxidation capacity. These mice also had greater food intake but 
were protected from age- and diet-induced obesity, glucose intolerance, and 
hepatosteatosis through increased energy expenditure. Another study showed autophagy 
deficiency protects the mice from diet induced obesity and insulin resistance by inducing 
fibroblast growth factor 21 (Fgf21) 147. Due to induction of Fgf21, fatty acid oxidation 
and browning of white adipose tissue (WAT) was increased.  Similar to Clpp knockout 
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mice, these animals have reduced muscle and fat mass, lower body weight and enhanced 
energy expenditure. All these evidences gave us an indication towards a similar role 
CLPP in regulating the metabolism of the organism. These preliminary exciting results 
prompted us to perform further experiments to know if CLPP plays a role in protecting 
the mice against age and diet induced obesity and insulin resistance.  
We report here that CLPP, one of the key members of the mitochondrial quality control 
team, has some new and unexpected roles in regulation of ribosomal biogenesis and 
mitochondrial translation. Label free quantification analysis of mitochondrial proteome 
gave the initial hint that CLPP might be regulating various substrates or candidates 
involved in processes such as respiratory chain & oxidative phosphorylation (OXPHOS), 
translation processes and metabolic processes. While investigating the role of CLPP in 
biochemical and molecular pathways, we observed an early specific decrease in Complex 
I activity, followed by a decrease in Complex IV activity later in life in Clpp knockout 
mice. We did not observe major changes in mtDNA levels although the previous study 
study in Clpp knockout mice reported increased levels of mtDNA levels 114. This 
discrepancy might be due to the difference in techniques used in both analyses. We have 
quantified through Southern blot analysis while the other study used a semi-quantitative 
RT-PCR method. In addition, this study also showed no significant changes in the steady 
state levels of TFAM 114.  Since it has been shown that TFAM is necessary for mtDNA 
maintenance 127, increase in mtDNA levels is usually correlated with the increase in 
steady state levels of TFAM. Hence increase in mtDNA levels with unchanged levels of 
TFAM is less likely. We also did not observe any major change in the levels of TFAM 
(data not shown). Mitochondrial dysfunction usually triggers a compensatory activation 
of mitochondrial biogenesis, which is often accompanied by an increase in steady state 
levels of mtDNA along with increase in mitochondrial transcription. This is evident from 
studies in various mouse models with mitochondrial dysfunction lacking genes essential 
for mtDNA expression, posttranscriptional modifications and other mitochondrial factors 
such as TFB1M 34, MTERF4 41, MTERF3 40 and NSUN4142. Interestingly in Clpp 
knockout mice we do not see any compensatory activation of mitochondrial biogenesis, 
however, we do observe an increase in mitochondrial transcription. This upregulation in 
transcription is most likely to be a compensatory response to the observed decrease in 
mitochondrial translation in Clpp deficient mice. This upregulation of mitochondrial 
transcription might be one of the early responses to either a mild hindrance in translation 
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or defect in ribosome function, also suggesting that transcription and translation are 
oppositely coordinated. These results obtained from Clpp deficient mice are in 
accordance to other mouse models with mitochondrial dysfunction lacking genes 
essential for mtDNA expression, posttranscriptional modifications and other 
mitochondrial factors. All these mouse models; TFB1M 34, MTERF4 41, MTERF3 39,40 
and NSUN4 142, caused defective translation and increase in de novo transcription with 
increased steady state levels of most of mitochondrial transcripts. Hence decrease in 
mitochondrial translation in absence of CLPP suggested a direct or indirect role of CLPP 
in the process of mitochondrial protein synthesis. Moreover, similar to Mterf3 39, 40 
knockout mice, we observed a decrease in steady state levels of 16S rRNA although the 
levels of 12S rRNA were mildly decreased. But the levels of RNA19 that encompasses 
16S rRNA and ND1 were increased suggesting impairment in the processing of RNA 19 
that might result in lower levels of 16S rRNA. We also found a significant accumulation 
of precursors for other mRNAs and tRNAs in Clpp deficient mice. Though, accumulation 
of precursors has been reported in other studies 41,126, its accumulation in Clpp deficient 
mice seems to be very interesting. MRPP1 that essential for RNA modification and 
translation 124 is likely to be a substrate of CLPP, indicating a role of CLPP in the 
processing of transcripts.  
The mild decrease in steady state levels of 12S rRNA might suggest towards an 
impairment of the stability of small ribosomal subunit. In Tfb1m knockout mice steady 
state levels of 12S rRNA were significantly reduced34. In this study it was shown that 
lack of TFB1M resulted in the loss of dimethylation of 12S rRNA followed by decrease 
in steady state levels of 12S rRNA, instability of the small subunit of the ribosome 
thereby disrupting formation of mitochondrial monosomes. Even though in our study we 
did not obtain a strong phenotype similar to TFB1M, lower steady state levels of 12S 
rRNA might indicate towards a mild impairment of stability of small ribosomal subunit. 
This might have resulted in the increase in the steady state levels of small ribosomal 
subunit and likely be the initiation point of mild impairment in translation in Clpp 
deficient mice. 
Surprisingly, we found, via gradient sedimentation analysis that the mitochondrial 
ribosomes appears to be assembled properly and present in almost normal levels. This 
result was quiet perplexing since earlier studies demonstrated impaired mitoriobosome 
assembly as the cause behind the observed translational defect 34,40,41,142. In Tfb1m 
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knockout mice, there was a deficiency of assembled small ribosomal subunit (SSU) and 
an increase in large ribosomal subunit (LSU) thereby affecting the formation or stability 
of the monosomes 34. In Mterf4 knockout, there was a drastic increase in levels of both 
SSU and LSU but no corresponding increase in levels of monosomes. This could be 
either lack of interaction between SSU and LSU to form monosomes or the stability of 
fully assembled monosomes could be affected 41. In Mterf3 deficient mice there was an 
increase in levels of SSU but decrease in levels of LSU and low amount of monosomes at 
younger stage. In addition, at later stages the levels of LSU significantly decreased that 
resulted in complete disruption of assembled monosomes. In Nsun4 knockout mice it was 
shown an accumulation of assembled SSU and LSU without a corresponding increase in 
assembled ribosomes suggesting inhibition of association between the SSU and LSU to 
form functional ribosomes. However, in Clpp deficient mice we observe an increase in 
the levels of SSU and minor increase in levels of LSU whereas monosomes are present in 
almost normal levels and likely to be assembled properly.  
Another striking feature was the massive increase in the steady state levels of small 
ribosomal subunits, while large ribosomal subunits were present in almost normal levels. 
This suggests either a problem with the assembly small ribosomal subunit as mentioned 
before or a complexity with the large ribosomal subunit where the increase in steady state 
levels of small ribosomal subunits is a compensatory response to it. It might also be 
possible that the stability of small ribosomal subunit is affected due to absence of any 
single small subunit.  However, these possibilities lead to some open questions, if the 
stability of mitoribosomes is mildly affected or not and/or if these mitoribosomes are 
functional or not.  
Further investigation revealed an impairment of 12S rRNA assembly into mitoribosomes 
leading to lower loading of mt-mRNAs. We noticed that in a particular time, only a 
fraction of mRNAs was getting translated which might a possible explanation behind the 
observed hindrance in translation process. Our finding correlates with another study 
showing abnormal interaction between ribosomal subunits and mRNAs as an explanation 
behind defective translation where there was no defect in the assembly of mitoribosomes 
111.  
Our results from identification of CLPP specific substrates helped us to streamline 
regarding the role of CLPP in regulating ribosomal biogenesis and translation. ERAL1, 
P32, EF-G1mt appeared to be the promising candidates that were likely to be involved in 
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this process.  In this study we show ERAL1 and EF-G1mt are the substrates of CLPP and 
P32 likely to be an interactor of CLPP.  
ERAL1:  
ERAL1 (Era G-protein like 1) is the mammalian orthologue of the E. coli Ras-like 
protein Era 148. In E. coli it has been shown that Era is essential for cell division 149. In 
addition, it has been reported that Era binds to the 30S small ribosomal subunit near to 
the 3’ terminus of the 16S rRNA suggesting its direct involvement in the functional 
assemble of 30S small ribosomal subunit of E. coli 150,151. Our data implies that ERAL1 is 
preferentially bound to the small subunit of the ribosome and to monosomes to a lesser 
extent in Clpp knockout mice. Previous studies have shown that ERAL1 which is a 
member of the conserved GTP binding proteins with RNA binding activity, act as a 
chaperone that protects 12S rRNA on the 28S mitoribosomal subunit during the assembly 
of small ribosomal subunit. It has been also shown ERAL1 associates with small 
ribosomal subunits and is involved in its assembly thereby forming functional small 
ribosomal subunits 116,117. But unexpectedly we observe that in absence of CLPP, ERAL1 
seems to be stuck with the small ribosomal subunit that too in a much higher abundance 
in Clpp knockout mice. It is also unknown about how ERAL1 itself is regulated. ERAL1 
being a chaperone of 12S rRNA is expected to leave after assembling the 12S rRNA 
component along with respective small subunit proteins to form the fully assembled and 
functional small subunit.  Since ERAL1 is still bound to small ribosomal subunit, this can 
be interpreted as involvement of ERAL1 causing an impairment of 12S rRNA assembly 
into small ribosomal subunit thereby finally leading to lower loading of mitochondrial 
mRNAs on monosomes. Moreover, this phenomenon of ERAL1 being bound to small 
ribosomal subunit arises some open questions regarding what is causing ERAL1 to still 
hang around with the small ribosomal subunit. It might be possible that either some small 
ribosomal subunit proteins are missing or if any assembly factor of small ribosomal 
subunit is absent. Although no assembly factors for small ribosomal subunit has been 
identified to date, but we can not rule out the presence of any assembly factors since they 
are required for assembling cytosolic ribosomes in various organisms. There can also be a 
probability that binding of ERAL1 to the small ribosomal subunit may interfere or block 
the association of some other proteins thereby impeding the assembly of the small 
ribosomal subunit or the association of the large subunit to form a fully functional 
monosome.  Hence, it would be interesting to know about the proteins associated with 
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ERAL1 in the Clpp knockout mice since this will give us further insight regarding the 
binding of ERAL1 to the small ribosomal subunit. In addition, we are currently 
performing experiments to show if there is any interaction between ERAL1 and CLPX. 
This may imply that in absence of CLPP, CLPX recognizes and binds ERAL1 but unable 
to produce to CLPP for subsequent degradation and thereby still bound with the small 
ribosomal subunit.  
On one hand, ERAL1 association to the small ribosomal subunit might be the cause for 
the decrease translation in Clpp knockout mice or the effect of not being able to be 
turnover or degraded in the absence of CLPP that leads to the series of events or 
consequences as mentioned above. 
P32: 
In this study, we report that P32 is likely to be an interactor of CLPP and is preferentially 
bound to large ribosomal subunit and monosomes. Our result is comparable to previous 
analysis where P32 was shown to be associated with mitoribosomes 118. P32 is mainly 
localized to mitochondrial matrix, but various studies have reported P32 to be present in 
other subcellular locations 132–135. P32 has been shown to be multifunctional possessing 
important roles in mitochondrial translation, correct functioning of mitoribosomes with 
mRNA, apoptosis, autophagy and regulating mitochondrial bioenergetics 118,136. It has 
also been proposed in various studies that P32 may act as a multifunctional chaperone 
protein 119,137,138. P32 is a very acidic doughnut shape protein whose one side is much less 
negatively charged and proposed to bind RNA whereas the acidic side might be involved 
in protein-protein interactions such as mitoribosome 133. So far it is not clear about how 
mRNA is fed into the mRNA entrance gate on the small ribosomal subunit.  Few studies 
have suggested that mRNA ‘entry gate’ on the small subunit recognizes the unique 
unstructured 5’sequence of mitochondrial mRNA47. It might be possible that P32 
mediates the binding of mRNA to the small ribosomal subunit thereby enhancing the 
formation of monosomes since it has been shown that P32 is essential for association of 
mRNAs with mitoribosomes. In this same study, P32 was found to significantly bind to 
RNA and stimulate translation. Hence it was proposed that RNA chaperone activity of 
P32 might contribute to transport RNAs to mitoribosomes thereby enhancing initiation of 
translation 118. Another possibility is P32 might be involved in guiding the 5’leaderless 
mRNA to mitoribosomes for initiation of translation either by enhancing the formation of 
mitoribosome or stabilizing mitoribosomes. These proposed roles could also hold true for 
 100 
Clpp knockout mice since we showed that P32 is bound to mitoribosomes and also 
interacts with CLPP. Interestingly, ERAL1 and CLPX were among the list of identified 
proteins in complex with P32 118. However, our data suggests that P32 interacts directly 
with CLPP and not with CLPX and therefore its interaction with CLPX is secondary.  
It could be that the complication is initiated at step 1 where ERAL1 is bound to the small 
ribosomal subunit thereby affecting its assembly and proper function. This event is 
followed by the subsequent consequences in the next series of events. One of them is P32 
being still bound to mitoribosomes, which is essential for association of mRNAs with 
small ribosomal subunit to enhance initiation of translation. However, since ERAL1 is 
still bound to ribosomes, the entire system senses some trouble, which instructs P32 to 
hang around with the mitoribosomes on one side and mRNAs on the other thereby 
resulting in lower loading of mitochondrial mRNAs on monosomes and decrease in 
mitochondrial translation.  
EF-G1mt: 
This is a factor involved in the elongation phase of mitochondrial translation. EF-G1mt is 
required for the translocation of the mitoribosome thereby moving deacylated tRNA out 
of the P-site and the peptidyl tRNA from the A-site to the P-site of mitoribosome 50. In 
this study we have shown EF-G1mt to be a substrate of CLPP and also associates with the 
mitoribosomes in Clpp knockout mice. EF-G1mt association with mitoribosomes in higher 
abundance is another striking feature since under normal condition of mitochondrial 
translation, once EF-G1mt and deacylated tRNA are released from the mitoribosomes a 
new cycle of elongation can begin. This might be another consequence sensing a problem 
that is initiated at step 1 where ERAL1 is bound to small ribosomal subunit.  
CLPX: 
In order to carry out protein degradation by CLPXP, it requires the collaboration of 
CLPX, which binds substrates, adaptors and CLPP. The main function of CLPX is to 
unfold the stable tertiary structure of the substrate and then translocate the unfolded 
polypeptide chain into the proteolytic compartment of ClpP for degradation. Previous 
study have proposed additional role of CLPX as a novel mtDNA regulator. It has been 
shown that CLPX acts as a chaperone thereby maintaining mtDNA nucleoid distribution 
through TFAM activity139.  Trapping and proteomic profiling of ClpP substrates in 
various organisms have revealed CLPX as one of the identified proteins similar to our 
analysis140, 141. In our study we show that CLPX is also bound to mitoribosomes in higher 
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abundance in Clpp knockout mice. We have also proven ERAL1 and EF-G1mt to be the 
substrates of CLPP that are recognized, captured, unfolded by CLPX followed by 
translocation into the proteolytic compartment of CLPP for degradation. One reason 
behind the association of the CLPX with mitoribosomes could be the consequence of the 
complication generated at initial step 1 involving ERAL1. Another reason could be that 
in absence of CLPP, CLPX might have captured CLPP specific substrates ERAL1 and 
EF-G1mt but unable to produce them for degradation. 
 
To conclude it appears that CLPP exhibits various roles in mammals. In this study we 
have shown the role of CLPP in regulation of mitochondrial ribosome biogenesis through 
two of the most promising identified candidates: ERAL1 and P32 where ERAL1 is 
substrate of CLPP and P32 likely to be an interactor. In addition, we have also presented 
some interesting preliminary results indicating towards a role of CLPP in mammalian 
metabolism. 
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